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Abstract
There are sex differences in disease susceptibility, time of onset of symptoms, and drug responses.
Notably, sex differences are particularly prominent in pain and opioid analgesic responses, with females
being less sensitive to opioid analgesia. A major site of action of opioids in the brain is the locus
coeruleus (LC)-norepinephrine (NE) system. LC neurons express mu-opiate receptors (MOR), and MORagonists potently inhibit LC neuronal activity. Evidence suggests that endogenous opioids are released
during stress, to restrain LC activation and to facilitate LC recovery when the stressor ends. On the basis
of these observations, this dissertation tested the hypothesis that the opioid regulation of the LC is
decreased in females relative to males. By implementing electrophysiological, biochemical, and
behavioral approaches, sex differences in MOR regulation of the LC-NE system were examined. MOR
mRNA was greater in male compared to female LC as indicated by quantitative PCR. This translated to an
increased level of MOR protein in male compared to female LC tissue as detected by Western blot
analysis. Consistent with sex differences in MOR expression in the LC, recordings of single unit LC activity
in anesthetized rats demonstrated that the maximal magnitude of inhibition produced by intracoerulear
injection of a MOR agonist, DAMGO, was greater in males. The decreased response of female LC neurons
to MOR activation was expressed as a diminished response in upstream targets. Thus, intra-LC DAMGO
increased synchronization of local field potential activity in male but not female medial prefrontal cortex
(mPFC). Notably, the LC-NE system affects cognitive function through its projections to the mPFC. The
molecular and cellular sex differences in MOR regulation of the LC were associated with sexually distinct
effects on cognitive processing in an operant strategy-shifting task. Intra-LC DAMGO increased the
duration to complete the task and the total number of errors, selectively in males. DAMGO increased
premature responses, regressive and random errors in males, and perseverative errors in females. The
sex-specific effects of LC-MOR activation on cognitive processing may contribute to an early onset of
opioid abuse in males, and susceptibility to opioid relapse in females. Ultimately, given the role of
endogenous opioids in restraining the stress response of the LC system, decreased opioid sensitivity in
females could enhance female vulnerability to stress.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Neuroscience

First Advisor
Rita J. Valentino

Keywords
Animal Model, Behavioral Neuroscience, Cognition, Locus Coeruleus, Opioids, Sex differences

Subject Categories
Molecular Biology | Neuroscience and Neurobiology | Social and Behavioral Sciences

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/2782

SEX DIFFERENCES IN µ-OPIOID REGULATION OF THE RAT LOCUS
COERULEUS
Herminio Manuel Guajardo
A DISSERTATION
in
Neuroscience
Presented to the Faculties of the University of Pennsylvania
in
Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2017
Supervisor of Dissertation
__________________________
Dr. Rita J Valentino
Professor of Anesthesiology and Critical Care,
The Children’s Hospital of Philadelphia/
University of Pennsylvania
Graduate Group Chairperson
__________________________
Dr. Joshua I. Gold,
Professor of Neuroscience,
Perelman School of Medicine at the University of Pennsylvania
Dissertation Committee
Dr. Marc Schmidt, Associate Professor of Biology, University of Pennsylvania (Chair)
Dr. Seema Bhatnagar, Associate Professor of Anesthesiology and Critical Care
The Children’s Hospital of Philadelphia/ University of Pennsylvania
Dr. Heath Schmidt, Assistant Professor of Psychiatry, Perelman School of Medicine, University
of Pennsylvania.
Dr. Alexxai Kravitz, Principal Investigator, NIDDK, NIDA, National Institutes of Health.
	
  

SEX DIFFERENCES IN µ-OPIOID REGULATION OF THE RAT LOCUS
COERULEUS
COPYRIGHT
2017
Herminio Manuel Guajardo

This work is licensed under the
Creative Commons AttributionNonCommercial-ShareAlike 3.0
License
To view a copy of this license, visit
http://creativecommons.org/licenses/by-ny-sa/
	
  

DEDICATION
For my God, for my mother Flora Elia Reyes,
for her love, dedication, prayers and guidance,
and for my family that supported me through this hard
but amazing experience.

	
  

iii	
  

ACKNOWLEDGEMENTS
I would like to acknowledge my thesis advisor Dr. Rita Valentino for her support
and mentorship during all these years in her laboratory. It was a terrific experience
working with her, and many great scientists in the neurobiology of stress division. Also, I
would like to acknowledge all the members of the Valentino Lab: Andre Curtis, XiaoYang Zang, Debbie Bangasser, Nayla Chaijale, Susan Wood, Kevin Snyder, Andrew Ho,
Gerard Zitnik, Anitha Manohar, Jay Arner, Kimberly Urban, Maiko Suarez, Kyle
McFadden, Maria Zilberman, Claire Carter, and Sonia Torres. They are great friends and
scientists.
I would like to especially thank Michael Nausbaum, Larry Palmer, Diego
Contreras, Joshua Gold, Rita Balice-Gordon, Jean Boyer (PennPREP), Teresa Milner
(Cornell), Francoise Freyre (Cornell), Luis V Colom (MBRS-RISE), Eldon Nelson
(MBRS-RISE), Lilly Morales (UTB), Sandra Gerace (MBRS-RISE), and Arnaldo Diaz
(PennPREP). I would not be where I am today if I didn't have the support of all these
great professors and administrators who helped and guided me, even before starting my
graduate career. Last but not least, I would like to thank all of my friends, Ivan Valdez,
Karina Gonzales, Orlando de la Garza, Angela Ortega Rodriguez, David Wei, Khaing
Wing, and Alda Rivas who have supported me during my graduate program.

	
  

iv	
  

ABSTRACT
SEX DIFFERENCES IN µ-OPIOID REGULATION OF THE RAT LOCUS
COERULEUS
Herminio Manuel Guajardo
Rita J. Valentino
There are sex differences in disease susceptibility, time of onset of symptoms, and
drug responses. Notably, sex differences are particularly prominent in pain and opioid
analgesic responses, with females being less sensitive to opioid analgesia. A major site of
action of opioids in the brain is the locus coeruleus (LC)-norepinephrine (NE) system. LC
neurons express mu-opiate receptors (MOR), and MOR-agonists potently inhibit LC
neuronal activity. Evidence suggests that endogenous opioids are released during stress,
to restrain LC activation and to facilitate LC recovery when the stressor ends. On the
basis of these observations, this dissertation tested the hypothesis that the opioid
regulation of the LC is decreased in females relative to males. By implementing
electrophysiological, biochemical, and behavioral approaches, sex differences in MOR
regulation of the LC-NE system were examined. MOR mRNA was greater in male
compared to female LC as indicated by quantitative PCR. This translated to an increased
level of MOR protein in male compared to female LC tissue as detected by Western blot
analysis. Consistent with sex differences in MOR expression in the LC, recordings of
single unit LC activity in anesthetized rats demonstrated that the maximal magnitude of
inhibition produced by intracoerulear injection of a MOR agonist, DAMGO, was greater
in males. The decreased response of female LC neurons to MOR activation was
expressed as a diminished response in upstream targets. Thus, intra-LC DAMGO
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increased synchronization of local field potential activity in male but not female medial
prefrontal cortex (mPFC). Notably, the LC-NE system affects cognitive function through
its projections to the mPFC. The molecular and cellular sex differences in MOR
regulation of the LC were associated with sexually distinct effects on cognitive
processing in an operant strategy-shifting task. Intra-LC DAMGO increased the duration
to complete the task and the total number of errors, selectively in males. DAMGO
increased premature responses, regressive and random errors in males, and perseverative
errors in females. The sex-specific effects of LC-MOR activation on cognitive processing
may contribute to an early onset of opioid abuse in males, and susceptibility to opioid
relapse in females. Ultimately, given the role of endogenous opioids in restraining the
stress response of the LC system, decreased opioid sensitivity in females could enhance
female vulnerability to stress.
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CHAPTER 1: INTRODUCTION
The goal of this dissertation is to determine the neural basis for sex bias in stressrelated neuropsychiatric diseases by studying sex differences in the regulation of a major
brain stress response system by endogenous opioids.
Sex Differences in Disease
Sex differences in brain function can arise from an assortment of genetic and
hormonal events that occur at early stages of development. These changes continue
throughout the lifespan of the organism and dictate the many physiological differences in
disease susceptibility, manifestation, and treatment between the sexes. In fact, it is well
known that there are differences between the sexes in disease susceptibility, time of onset
of symptoms, and drug response in conditions such as coronary heart disease, cancer,
obesity, autoimmune diseases, and mental health conditions, among others (Becker et al,
2005). Therefore, there is a general calling within the basic and clinical scientific
community to identify the biological bases for differences between males and females in
the development of disease, signs and symptoms of pathophysiology, and response to
therapy. Notably, the FDA has implemented regulations and guidance to ensure that both
sexes are represented in all phases of clinical trials, and medical products are labeled to
alert physicians and patients regarding sex-differences in drug responses (Soldin et al,
2011). This knowledge will advance our ability to target treatments for specific
individuals. Moreover, on a basic science level, this knowledge will help elucidate the
pathophysiology of diseases that exhibit sex differences.
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Sex Differences in Stress-related Psychiatric Disorders
Sex differences are particularly prominent in psychiatric diseases. For example,
women are diagnosed with anxiety and mood-related pathology at higher rates than men,
with many epidemiological studies indicating that the female-to-male ratio for these
disorders is approximately 2:1 (Gater et al, 1998; Weissman and Klerman, 1977). Many
psychiatric diseases that are more prevalent in females are associated with stress. For
example, stress may exacerbate or precipitate symptoms and the disorders are often
associated with dysfunctional stress responses (Gold and Chrousos, 2002; Heim and
Nemeroff, 2001; Wong et al, 2000). This has led to the hypothesis that higher rates of
certain psychiatric diseases in women are due to sex differences in stress response
systems. The primary mediators of stress response are corticotropin-releasing factor
(CRF) and glucocorticoids. In response to stress, CRF initiates the endocrine cascade that
culminates in glucocorticoid release (Vale et al, 1981). CRF also acts as a brain
neurotransmitter to elicit behavioral and autonomic responses to stress (Li et al, 1996).
Sex differences in CRF receptors have been identified. For example, CRF binding is
significantly greater in the basolateral and posteroventral nuclei of the amygdala of
female rats compared to male rats (Weathington and Cooke, 2012). This sex difference
could translate into increased anxiety following stressful events in females, which if true
in humans, would increase the predisposition of women to anxiety disorders such as
PTSD. In addition, our laboratory has identified sex differences in CRF1 receptor (CRF1)
signaling and trafficking in rat cortex and Locus Coeruleus (LC) neurons. For example,
CRF1-Gs association is greater in female cortex compared to males, and stress-induced
CRF1 association with β-arrestin 2, a step that is critical for CRF1 internalization is
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decreased in female compared to male rats. Consistent with this, stress induces CRF1
internalization in locus coeruleus (LC) neurons of male rats, but not female rats. This
makes CRF-receptive neurons of females more sensitive to low levels of CRF, and less
adaptable to high levels of CRF (Bangasser et al, 2010). Taken together, these
experimental data suggest that sex differences in CRF receptors render females into a
dysregulated state of stress reactivity that could be linked to the development of mood
and anxiety disorders.
The Locus Coeruleus –Norepinephrine System
The LC-norepinephrine (NE) system is a major stress response system in the brain
that is important for arousal and cognitive aspects of stress response. The LC is a small
nucleus of neurons located in the pons just lateral to the wall of the fourth ventricle
(Foote et al, 1983). The LC is one of seven noradrenergic subgroups (the A1-A7 groups)
in the rat brainstem (A6, in the nomenclature of Dahlstroem and Fuxe, 1964). All LC
neurons synthesize norepinephrine (NE) (Dahlstroem et al, 1964), and it is the primary
source of NE in the brain (Swanson, 1976; Swanson and Hartman, 1975). There are two
types of neurons observed within the LC; large multipolar cells (~35 mm) located in the
dorsal part of the LC and smaller fusiform cells (~20mm) located mainly in the ventral
LC (Grzanna and Molliver, 1980; Swanson, 1976). The LC projects to the spinal cord,
brainstem, cerebellum, hypothalamus, thalamus, basal telencephalon, and the entire
isocortex via highly collateralized projections (Dahlstroem et al, 1964; Moore and
Bloom, 1979). Notably, LC is the sole source of NE in many forebrain regions that have
been implicated in cognition such as cortex and hippocampus (Waterhouse et al, 1983).
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In addition to NE, experimental evidence suggests that several neuropeptides are
expressed within subsets of LC neurons. For example, galanin (Gal) is expressed in up to
80% of LC neurons (Holets et al, 1988). Gal modulates many behaviors in the brain such
as wake/sleep states, nociception, feeding, and parental behavior (Lang et al, 2015). LC
neurons co-expressing NE and Gal are found throughout the LC, but are most densely
localized to the dorsal and central LC (Holets et al, 1988). Another neuropeptide coexpressed in LC neurons is Neuropeptide Y (NPY), which is present in a smaller
population of LC neurons (~20 %) in the dorsal portion of the LC (Holets et al, 1988).
Many other neuropeptides such as acetylcholinesterase, neurotensin, and vasoactive
intestinal protein have been detected in small subsets of neurons in the LC (Sutin and
Jacobowitz, 1991).
The LC receives inputs from several brain regions that promote diversity of LC
function during different behaviors. Specifically, the LC receives multiple varied inputs,
which all influence LC firing to different extents. In the majority of instances, the
neurotransmitter involved in these inputs to the LC is known; however, some
neurotransmitters in these synaptic inputs remain unidentified. Major brain structures, for
example, areas of the neocortex, amygdala, hypothalamus, brainstem, and spinal cord
project to the LC (Figure 1 adapted from Schwarz and Luo (2015)).
Neocortex. The parietal, temporal, infralimbic, insular, and frontal cortices
project and provide limited input to the LC (Arnsten and Goldman-Rakic, 1984;
Cedarbaum and Aghajanian, 1978; Luppi et al, 1995). Moreover, there is a strong
reciprocal connection between the LC and the prefrontal cortex (PFC) (Jodo and AstonJones, 1997; Jodo et al, 1998; Singewald and Philippu, 1998). The projection from PFC
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to the LC is suggested to provide tonic activation of the LC (Jodo et al, 1998). Although
the neurotransmitter responsible for this activation is unclear, glutamate maybe involved
given that NMDA receptors are expressed in LC neurons (Samuels and Szabadi, 2008).
Amygdala. The LC receives an input from the central nucleus of the amygdala
(CNA) (Cedarbaum et al, 1978; Singewald et al, 1998; Wallace et al, 1989). The
projection from CNA to the LC is suggested to be involved in the observed increase in
LC activity in response to stressful stimuli (Berridge and Waterhouse, 2003). For
example, neurons containing CRF in the CNA, project to the LC and activate these cells
in response to stress (Van Bockstaele et al, 1998).
Hypothalamus. The ventrolateral preoptic area of the hypothalamus sends an
inhibitory projection to the LC via its GABAergic neurons (Cedarbaum et al, 1978; Lee
et al, 2005; Simson, 2001; Steininger et al, 2001). Furthermore, the paraventricular
nucleus (PVN) of the hypothalamus, projects to the LC (Aston-Jones et al, 1986;
Cedarbaum et al, 1978; Luiten et al, 1985; Luppi et al, 1995; Reyes et al, 2005; Simson,
2001; Swanson and Sawchenko, 1980). CRF has been suggested as the primary
neurotransmitter in the projection to the LC, since excitatory CRF immunoreactive fibers
in the PVN have been found to project to, and increase the activity of the LC (Reyes et al,
2005). The lateral hypothalamic/perifornical area projects to the LC (Cedarbaum et al,
1978; Lee et al, 2005) with fibers that contain orexin peptides (Date et al, 1999; Espana
et al, 2005; Horvath et al, 1999; Peyron et al, 1998). Administration of orexin into the LC
has been found to increase cell firing (Date et al, 1999; Hagan et al, 1999), suppress
REM sleep, and increase wakefulness (Bourgin et al, 2000). The tuberomamillary
nucleus (TMN), which is mainly composed of histaminergic neurons, has been found to
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project to the LC (Iwase et al, 1993; Lee et al, 2005). TMN neurons are known to
promote wakefulness, and histamine H3 receptors have been identified on the cell bodies
of LC neurons, where they inhibit NE release (Haas and Panula, 2003; Pieribone et al,
1994).
Brainstem. The ventral tegmental area (VTA) neurons project to the LC
(Beckstead et al, 1979; Deutch et al, 1986; Oades and Halliday, 1987; Ornstein et al,
1987; Simon et al, 1979; Swanson, 1982). These VTA neurons are dopaminergic and
may contribute to the maintenance of arousal (Samuels et al, 2006, 2007). Different areas
of the raphe nuclei project to the LC. Strong evidence suggests that the serotonergic
neurons of the dorsal raphe project to the LC (Cedarbaum et al, 1978; Kim et al, 2004;
Luppi et al, 1995; Pasquier et al, 1977; Sim and Joseph, 1993; Simson, 2001; Vertes and
Kocsis, 1994), and this input is likely related to the wakefulness-promoting roles of the
dorsal raphe. The raphe magnus neurons have been reported to project to the LC (Sim
and Joseph, 1992), and this connection is thought to be related to the modulation of
nociception (Sim et al, 1992). Cholinergic neurons from pedunculopontine (PPT) and
laterodorsal tegmental nuclei (LDT) have been found to project to the LC (Jones and
Yang, 1985). PPT and LDT neurons are known to be active during wakefulness or REM
sleep (el Mansari et al, 1989; Jones, 2005; Kayama et al, 1992). Local microinfusion of
acetylcholine or acetylcholine receptor agonists into the LC increase the firing of LC
neurons (Egan and North, 1985; Engberg and Svensson, 1980), suggesting an excitatory
role for the PPT and LDT projection to the LC. LC receives an input from neurons of the
periaqueductal grey matter (PAG) in the midbrain (Cedarbaum et al, 1978; Lee et al,
2005; Luppi et al, 1995; Simson, 2001), particularly from the dorsolateral cell column of
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the PAG (Cameron et al, 1995). PAG neurons that project to the LC are diverse in
neurotransmitter content; ventral PAG neurons are dopaminergic (Lu et al, 2006), and are
suggested to be involved in the activation of LC neurons during wakefulness. In addition,
the ventral and ventrolateral PAG are suggested to be involved in the regulation of sleepwakefulness state via inhibitory glycinergic projections to the LC (Rampon et al, 1999).
Tract-tracing and electrophysiology studies have revealed that major inputs to the LC are
found in two structures, the nucleus paragigantocellularis (PGi) and the perifascicular
area of the nucleus prepositus hypoglossi (PrH), both located in the rostral medulla
(Aston-Jones et al, 1991; Luppi et al, 1995). The projection from the PrH to the LC
contains GABAergic neurons, and is thus inhibitory to LC neuronal activity (Ennis and
Aston-Jones, 1989a, b). This GABAergic projection is likely to be involved in the
inhibition of LC activity during REM sleep (Verret et al, 2006). On the other hand, PGi
projections to the LC are excitatory via the release of glutamate (Simson, 2001). In
addition to the GABAergic and glutamatergic projections to the LC from the rostral
medulla, both the PrH and the PGi innervate the LC with fibers containing the
endogenous opiate enkephalin (Drolet et al, 1992; Johnson et al, 2002; Van Bockstaele,
1998). These projections activate opiate receptors found in high concentrations in the LC
to inhibit cell firing (Toyama et al, 1974; Van Bockstaele, 1998), and the administration
of endogenous opioids or opiate agonists inhibits spontaneous firing of the LC (Illes and
Norenberg, 1990; Korf et al, 1974; Mansour et al, 1994; Pepper and Henderson, 1980;
Pert and Snyder, 1976b; Valentino and Wehby, 1988c; Williams and North, 1984).
Spinal cord. The LC receives projections from the dorsal horn of the spinal cord
(Cedarbaum et al, 1978; Craig, 1992). It has been suggested that this pathway may
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communicate information relating to the detection of nociceptive and/or thermal stimuli
from sensory spinal nuclei (Craig, 1992). However, it is unclear the neurotransmitter
responsible for this communication (Samuels et al, 2008).
Electrophysiological studies on LC neuronal activity have determined that LC
neurons exhibit two distinct modes of activity: tonic and phasic (Aston-Jones and Cohen,
2005). The tonic rate of LC neuronal discharge has been correlated with behavioral
arousal (Aston-Jones and Bloom, 1981a; Foote et al, 1980). Additionally,
pharmacological manipulation of tonic LC neuronal activity has been shown to impact
electroencephalographic indices of arousal (Berridge and Foote, 1991; Berridge et al,
1993). LC neurons respond phasically to a broad range of sensory stimuli (Aston-Jones
and Bloom, 1981b; Foote et al, 1980). The phasic response precedes the orientation
towards the stimulus, and may be a signal to redirect behavior towards salient stimuli.
The phasic pattern of discharge is characterized by a brief excitatory component followed
by a longer duration of inhibition. This is consistent with evidence for a role of excitatory
amino acid (i.e., glutamate) neurotransmission in LC sensory responses (Ennis et al,
1992), as these agents produce a robust, albeit brief, activation of LC neurons. The
extensive distribution of the axonal network of the LC provides tonic and phasic arousalrelated signals to the forebrain. These signals have been suggested to direct attention
toward behaviorally relevant sensory information (Aston-Jones et al, 2005). It was
originally hypothesized that the primary role of the LC-NE system was to regulate
arousal and sleep-wake cycles (Berridge et al, 2012); however, the two distinct modes of
LC activity (i.e. tonic and phasic) indicate a more specific role in the cognitive processing
of relevant sensory information (Aston-Jones et al, 2005). For example, phasic firing of
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LC neurons, specifically in response to behavioral tasks that are relevant for sensory
stimuli, mediates focused attention and optimal task performance; yet, when rewards
associated with task performance based on the current attentional strategy cease, LC
activity switches to a high tonic mode until a more favorable strategy can be determined.
The shift from phasic to high tonic LC discharge has been suggested to promote
behavioral flexibility, disengaging animals from attention to specific stimuli and ongoing
behaviors and favoring scanning the environment for stimuli that promote alternate, more
rewarding behaviors (Aston-Jones et al, 2005). Notably, the prefrontal cortex (PFC)
mediates executive functions such as cognitive flexibility, a function thought to be
influenced by the LC-NE projections that target PFC neurons (Arnsten, 2011).
Pharmacological studies suggest a relationship between LC and PFC activity which
resembles an inverted U-shaped function, such that the PFC function requires an optimal
level of LC input, beyond which increases in LC drive negatively impact PFC function as
a result of the interaction of higher levels of NE with lower-affinity adrenergic receptors
(Arnsten, 2011).
The Locus Coeruleus –Norepinephrine System, Stress, and CRF
Several studies suggest that stressors that trigger the initiation of the
hypothalamic-pituitary-adrenal (HPA) response to stress, activate in parallel the LC-NE
system. The parallel engagement of these two systems helps to coordinate the endocrine
and cognitive limbs of the stress response (Valentino and Van Bockstaele, 2008). LC-NE
activation by stressors is mediated by CRF release in the LC because LC-NE activation is
blocked by administration of CRF antagonists into the LC (Valentino and Wehby,
1988b). CRF was initially characterized as the paraventricular hypothalamic
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neurohormone that initiates anterior pituitary adrenocorticotropin secretion in response to
stressors (Vale et al, 1981). The neuromodulatory actions of CRF are mediated through
two distinct receptors, CRF1 and CRF2, differentially distributed throughout the brain
(Primus et al, 1997; Van Pett et al, 2000). CRF1 activation, which has been clearly
associated with promotion of stress-response behaviors and activation of CRF2, originally
thought to dampen stress sensitivity, may actually function in other stress-related
responses, including stress-associated learning (Bale and Vale, 2004; Hauger et al, 2009).
Electron microscopic studies have shown that CRF-immunoreactive axon terminals form
synaptic specializations with LC dendrites in the core and peri-LC, with a majority of
these synapses being asymmetric, and thus excitatory in function (Van Bockstaele et al,
1996c). Many CRF axon terminals in the LC co-localize glutamate, while fewer colocalize enkephalin and GABA (Tjoumakaris et al, 2003; Valentino et al, 2001). CRF
axon terminals are also found next to unlabeled terminals that form synaptic
specializations with LC dendrites, providing a mechanism for indirect presynaptic
modulation of LC activity (Van Bockstaele et al, 1996c). During periods of stress, CRF is
released from a number of brain regions. Notably, CRF afferent to LC dendrites in the
peri-LC derive from the CNA and the PVN of the hypothalamus (Reyes et al, 2005;
Valentino et al, 1992; Van Bockstaele et al, 1998; Van Bockstaele et al, 1999), whereas
those afferent to the nuclear LC include the nucleus paragigantocellularis, Barrington's
nucleus and the paraventricular hypothalamic nucleus (Reyes et al, 2005; Valentino et al,
1996; Valentino et al, 1992). Hypothalamic CRF neurons that project to the LC are a
distinct population from those that project to the median eminence to regulate
adrenocorticotropin release (Reyes et al, 2005).
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CRF increases spontaneous LC discharge rates when locally administered into the
LC, either in vivo or in vitro (Curtis et al, 1997; Jedema and Grace, 2004). CRF in the LC
interacts with Gs-protein coupled CRF receptor 1 (Reyes et al, 2007). This stimulates
adenylate cyclase (Bale et al, 2004), ultimately leading to depolarization of LC neurons
through a cyclic AMP-dependent reduction in potassium conductance (Jedema et al,
2004; Schulz et al, 1996). LC activation by CRF is associated with c-fos expression by
LC neurons and norepinephrine release in terminal fields (Page and Abercrombie, 1999;
Rassnick et al, 1998). Notably, in vivo studies have shown that intracerebroventricular or
direct CRF administration into the LC can mimic the effects of stressors on LC neuronal
activity (Valentino et al, 1988b). LC activation by CRF is translated to activation of
cortical electroencephalographic (EEG) activity, indicative of increased arousal (Curtis et
al, 1997) and enhanced behavioral flexibility in a rat attentional set-shifting task (Snyder
et al, 2012). In addition to increasing spontaneous or tonic LC discharge rates, CRF
attenuates phasic sensory-evoked LC activity (Valentino and Foote, 1987, 1988a). This
may occur through presynaptic inhibition as suggested by electron microscopic studies
that show that CRF axon terminals also synapse with synaptic specializations in LC
dendrites, possibly providing a mechanism for the indirect presynaptic modulation of LC
activity (Van Bockstaele et al, 1996c). Given the evidence for co-localization of CRF and
glutamate in axon terminals in the LC, and convergence onto common LC dendrites,
there are multiple potential mechanisms for this interaction. The net effect of CRF on LC
neurons is to shift the mode of LC discharge to a high tonic-low phasic state (Valentino et
al, 1987, 1988a; Valentino et al, 2008). This mode of firing has been associated with high
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arousal (Butler et al, 1990), decreased focused attention, and increased behavioral
flexibility or going off-task in a search for optimal outcomes (Aston-Jones et al, 2005).
Under normal physiological conditions, the LC-NE system is not under tonic
regulation by endogenous CRF because CRF antagonists have no effect on either LC
discharge rates or norepinephrine release in LC upstream targets (Curtis et al, 1994; Page
et al, 1999). However, there is important evidence suggesting that acute stressors elicit
the release of endogenous CRF within the LC to activate LC neurons during acute stress.
For example, hypotensive challenge, which activates the HPA axis, mimics the effects of
CRF on tonic and phasic LC discharge (Valentino et al, 1988b). In addition, stressors
such as non-noxious visceral stimuli (colon distention) increase LC discharge rates, and
cortical EEG activity by a CRF-dependent mechanism (Lechner et al, 1997). Taken
together, the anatomical and electrophysiological evidence supports a model whereby
acute stress engages CRF inputs to the LC to bias activity towards a high tonic state that
would favor increased arousal and behavioral flexibility.
Locus Coeruleus Co-regulation during Acute Stress: CRF and Endogenous Opioids
Anatomical and electrophysiological evidence suggests that LC neurons are coregulated by CRF and the endogenous opioid, enkephalin during acute stress. The LC
expresses µ, δ and κ-opioid receptors. Notably, µ-opioid receptors (MOR) are
localized post-synaptically, while δ and κ are mainly expressed pre-synaptically in the
LC (Kreibich et al, 2008; Reyes et al, 2009; Van Bockstaele et al, 1995; Van Bockstaele
and Chan, 1997; Van Bockstaele et al, 1996a). MORs are highly expressed by LC
neurons to potently inhibit activity (Mansour et al, 1994; Pert et al, 1976b; Williams et
al, 1984). The LC receives projections from the endogenous opioid ENK system that

	
  

12	
  

innervates both the LC core and pericoeruleular region (Van Bockstaele et al, 1995; Van
Bockstaele et al, 1997). ENK projections arise from the rostral medullary nuclei
including the PGi and PrH (Aston-Jones et al, 1986; Drolet et al, 1992). ENK axon
terminals co-localizes with GABA (Van Bockstaele, 1998; Van Bockstaele et al, 1997)
and glutamate axon terminals (Barr and Van Bockstaele, 2005; Van Bockstaele et al,
2000) on LC dendrites. The endogenous opioid dynorphin (DYN) has afferents to the LC
that arise from the CNA (Reyes et al, 2008), which project onto κ-opioid receptors
(KORs) that are located pre-synaptically in axon terminals of the LC containing
glutamate transporter or CRF (Kreibich et al, 2008). Electrophysiological evidence
suggests that endogenous opioids are not tonically released onto LC under normal
physiologic conditions, because opioid antagonist administration has no effect on LC
baseline activity (Valentino and Wehby, 1989). In general, opioid receptor agonists
decrease LC firing rates. However, receptor specificity exists in how these responses are
changed. MOR-agonists are inhibitory on tonic LC neuronal discharge in vitro, as well as
in vivo (Aghajanian and Wang, 1987; Valentino et al, 1988c; Williams et al, 1984). For
example, the local application of morphine or enkephalin (ENK) inhibits the spontaneous
activity of LC neurons through activation of MORs and hyperpolarization with increased
potassium conductance (Aghajanian et al, 1987; Bird and Kuhar, 1977; North and
Williams, 1985). Moreover, phasic responses are facilitated, increasing the signal to noise
ratio of LC evoked activity (Valentino et al, 1989). In contrast, KOR agonist
administration diminishes phasic LC activity, as well as stress-mediated CRF activation
of the LC (Kreibich et al, 2008).

	
  

13	
  

LC dendrites receive convergent input from CRF and enkephalin-containing axon
terminals and co-localize MOR and CRF1 (Reyes et al, 2007; Tjoumakaris et al, 2003;
Xu et al, 2004). Recordings of LC neuronal activity during acute stress indicate that
stressors release both CRF and enkephalin to co-regulate LC activity in opposing
manners. The net overall effect is a CRF-mediated excitation. However, removal of this
influence using a CRF antagonist reveals a naloxone-mediated inhibition. This inhibition
restrains the CRF activation and also facilitates a return towards baseline activity when
the stressor is terminated (Curtis et al, 2001; Curtis et al, 2012). These CRF-opioid
interactions adjust the activity and reactivity of LC neurons so that the level of arousal
and processing of sensory stimuli are optimized to facilitate adaptive behavioral
responses to stressors (Figure 2 adapted from (Valentino and Van Bockstaele, 2015)).
Sex Differences in Response to Opioids
Sex differences in opioid sensitivity have been reported in laboratory animals and
humans, with females being less sensitive to morphine-induced analgesia and more
sensitive to experimentally-induced pain compared to males (Kest et al, 2000a). For
example, of 50 analgesic assay comparisons, male rodents exhibited more robust
analgesia than females in 28 (56%) assays, females showed greater analgesia in 2 (4%)
assays, and there were no sex differences in 20 (40%) assays (Kest et al, 2000b). In
addition, male animals typically have a greater analgesic response to opioids compared to
females (Craft, 2003). Consistent with data from studies in rodents, studies in humans
determined that women exhibit higher pain intensity after surgery and have larger
weight–adjusted morphine requirements than men, to achieve a similar degree of
analgesia(Cepeda and Carr, 2003). The higher requirement of morphine for females to
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improve pain suggests less sensitivity to the drug. Taken as a whole, these findings
suggest a decreased sensitivity of females to the analgesic effects of opiates.
Sex Differences in Opioid Regulation of the LC: a Potential Determinant of Stress
Vulnerability
Given the role of endogenous opioids in restraining the stress response of the LC
system, excessive or insufficient opioid influence in the LC may have pathological
implications. Individual differences in either enkephalin expression or MOR sensitivity
are potential determinants of stress vulnerability or vulnerability to pathology. For
example, decreased MOR function may predispose to hyperarousal symptoms of stress
related neuropsychiatric disorders because of a decreased ability to temper CRF effects in
the LC. On the other hand, greater MOR sensitivity could be predicted to protect from
hyperarousal symptoms in stress-related pathologies. Importantly, sex and hormonal
status can affect expression, sensitivity, and trafficking of MORs, as well as enkephalin
expression (Craft, 2008; Gonzales et al, 2011; Milner et al, 2013). However, these
relationships are not well understood and may be dependent on the species, brain region,
or endpoint. Notably, it is well documented that females are less responsive to opiates (Ji
et al, 2006; Kepler et al, 1991; Wang et al, 2006) and this would be consistent with
reports that stress-related diseases characterized by hyperarousal are more prevalent in
females (Breslau, 2002; Kessler et al, 1994; Kessler et al, 1995). Given the role of
endogenous opioids in restraining the stress response of the LC system, decreased opioid
sensitivity in females could increase the stress-sensitivity of this system, and enhance
female vulnerability to stress.
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Conclusion
Given that there are sex differences in stress-related diseases characterized by
hyperarousal symptoms that are more prevalent in females compared with males
(Breslau, 2002; Kessler et al, 1994; Kessler et al, 1995), observations indicating that
females are less responsive to opiates (Ji et al, 2006; Kepler et al, 1991; Wang et al,
2006), and the important role of endogenous opioids in restraining stress-related
activation of LC neurons, Chapter 2 investigates sex differences in MOR expression in
the LC, and the neuronal and behavioral consequences of MOR activation in the LC of
male and female rats. Chapter 3 further explores how molecular and cellular sex
differences of the LC-MOR system translates to changes in neuronal activity in PFC
regions that guide cognitive strategies. Ultimately, the studies in Chapters 2 and 3, which
examine sex differences in opioid regulation of the LC may have a significant impact on
the field by helping to elucidate a molecular mechanism that explains why there are
higher rates of females being diagnosed with stress-related psychiatric disorders.
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Figures and Legends

	
  

Figure 1. Afferent projections to the LC-NE system.
A saggital schematic illustrating the LC in the brainstem (red), and brain regions that
provide the largest fraction of direct input to the LC-NE neurons (dark gray arrows) and
their respective neurotransmitters. Abbreviations: PAG, periaqueductal gray; VTA,
ventral tegmental area; RN, raphe nucleus; POA, preoptic area; PPT, pedunculopontine
tegmental nuclei; LDT, laterodorsal tegmental nuclei; PGi, nucleus paragigantocellularis;
PrH, nucleus prepositus hypoglossi; SC, spinal cord; ORX, orexin; HIS, histamine; ENK,
enkephalin; GLUT, glutamate; CRF, corticotropin releasing factor; Ach, acetylcholine;
GABA, gamma-Aminobutyric acid; SER, serotonin. Figure adapted from Schwarz et al
(2015).

	
  

17	
  

Figure 2. The opposing regulation model of LC activity during acute stress.

	
  

During acute stress, both CRF (red) and endogenous opioids (yellow) afferents to the LC
are engaged. The net effect is a shift of LC activity towards high tonic activity that is
associated with increased arousal, scanning attention, and behavioral flexibility.
Endogenous opioids act as a restraint and facilitate recovery of neuronal activity to prestress levels after the stress is terminated. Figure adapted from Valentino et al (2015).

	
  

18	
  

References

Arnsten AF (2011). Catecholamine influences on dorsolateral prefrontal cortical
networks. Biological psychiatry 69 (12): e89-99.
Aston-Jones G, Bloom FE (1981a). Activity of norepinephrine-containing locus
coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking
cycle. The Journal of neuroscience : the official journal of the Society for
Neuroscience 1 (8): 876-886.
Aston-Jones G, Bloom FE (1981b). Norepinephrine-containing locus coeruleus neurons
in behaving rats exhibit pronounced responses to non-noxious environmental
stimuli. The Journal of neuroscience : the official journal of the Society for
Neuroscience 1 (8): 887-900.
Aston-Jones G, Cohen JD (2005). An integrative theory of locus coeruleusnorepinephrine function: adaptive gain and optimal performance. Annual review
of neuroscience 28: 403-450.
Bangasser DA, Curtis A, Reyes BA, Bethea TT, Parastatidis I, Ischiropoulos H, et al
(2010). Sex differences in corticotropin-releasing factor receptor signaling and
trafficking: potential role in female vulnerability to stress-related
psychopathology. Molecular psychiatry 15 (9): 877, 896-904.
Becker JB, Arnold AP, Berkley KJ, Blaustein JD, Eckel LA, Hampson E, et al (2005).
Strategies and methods for research on sex differences in brain and behavior.
Endocrinology 146 (4): 1650-1673.

	
  

19	
  

Berridge CW, Foote SL (1991). Effects of locus coeruleus activation on
electroencephalographic activity in neocortex and hippocampus. The Journal of
neuroscience : the official journal of the Society for Neuroscience 11 (10): 31353145.
Berridge CW, Page ME, Valentino RJ, Foote SL (1993). Effects of locus coeruleus
inactivation on electroencephalographic activity in neocortex and hippocampus.
Neuroscience 55 (2): 381-393.
Berridge CW, Schmeichel BE, Espana RA (2012). Noradrenergic modulation of
wakefulness/arousal. Sleep medicine reviews 16 (2): 187-197.
Breslau N (2002). Gender differences in trauma and posttraumatic stress disorder. The
journal of gender-specific medicine : JGSM : the official journal of the
Partnership for Women's Health at Columbia 5 (1): 34-40.
Butler PD, Weiss JM, Stout JC, Nemeroff CB (1990). Corticotropin-releasing factor
produces fear-enhancing and behavioral activating effects following infusion into
the locus coeruleus. The Journal of neuroscience : the official journal of the
Society for Neuroscience 10 (1): 176-183.
Cepeda MS, Carr DB (2003). Women experience more pain and require more morphine
than men to achieve a similar degree of analgesia. Anesthesia and analgesia 97
(5): 1464-1468.
Craft RM (2003). Sex differences in opioid analgesia: "from mouse to man". The Clinical
journal of pain 19 (3): 175-186.

	
  

20	
  

Craft RM (2008). Sex differences in analgesic, reinforcing, discriminative, and motoric
effects of opioids. Experimental and clinical psychopharmacology 16 (5): 376385.
Curtis AL, Bello NT, Valentino RJ (2001). Evidence for functional release of
endogenous opioids in the locus ceruleus during stress termination. The Journal of
neuroscience : the official journal of the Society for Neuroscience 21 (13): Rc152.
Curtis AL, Lechner SM, Pavcovich LA, Valentino RJ (1997). Activation of the locus
coeruleus noradrenergic system by intracoerulear microinfusion of corticotropinreleasing factor: effects on discharge rate, cortical norepinephrine levels and
cortical electroencephalographic activity. The Journal of pharmacology and
experimental therapeutics 281 (1): 163-172.
Curtis AL, Leiser SC, Snyder K, Valentino RJ (2012). Predator stress engages
corticotropin-releasing factor and opioid systems to alter the operating mode of
locus coeruleus norepinephrine neurons. Neuropharmacology 62 (4): 1737-1745.
Dahlstroem A, Fuxe K (1964). EVIDENCE FOR THE EXISTENCE OF
MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS
SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES
OF BRAIN STEM NEURONS. Acta physiologica Scandinavica Supplementum:
Suppl 232:231-255.
Drolet G, Van Bockstaele EJ, Aston-Jones G (1992). Robust enkephalin innervation of
the locus coeruleus from the rostral medulla. The Journal of neuroscience : the
official journal of the Society for Neuroscience 12 (8): 3162-3174.

	
  

21	
  

Ennis M, Aston-Jones G, Shiekhattar R (1992). Activation of locus coeruleus neurons by
nucleus paragigantocellularis or noxious sensory stimulation is mediated by
intracoerulear excitatory amino acid neurotransmission. Brain research 598 (1-2):
185-195.
Foote SL, Aston-Jones G, Bloom FE (1980). Impulse activity of locus coeruleus neurons
in awake rats and monkeys is a function of sensory stimulation and arousal.
Proceedings of the National Academy of Sciences of the United States of America
77 (5): 3033-3037.
Foote SL, Bloom FE, Aston-Jones G (1983). Nucleus locus ceruleus: new evidence of
anatomical and physiological specificity. Physiological reviews 63 (3): 844-914.
Gater R, Tansella M, Korten A, Tiemens BG, Mavreas VG, Olatawura MO (1998). Sex
differences in the prevalence and detection of depressive and anxiety disorders in
general health care settings: report from the World Health Organization
Collaborative Study on Psychological Problems in General Health Care. Archives
of general psychiatry 55 (5): 405-413.
Gold PW, Chrousos GP (2002). Organization of the stress system and its dysregulation in
melancholic and atypical depression: high vs low CRH/NE states. Molecular
psychiatry 7 (3): 254-275.
Gonzales KL, Chapleau JD, Pierce JP, Kelter DT, Williams TJ, Torres-Reveron A, et al
(2011). The influences of reproductive status and acute stress on the levels of
phosphorylated mu opioid receptor immunoreactivity in rat hippocampus.
Frontiers in endocrinology 2 (18).

	
  

22	
  

Heim C, Nemeroff CB (2001). The role of childhood trauma in the neurobiology of mood
and anxiety disorders: preclinical and clinical studies. Biological psychiatry 49
(12): 1023-1039.
Jedema HP, Grace AA (2004). Corticotropin-releasing hormone directly activates
noradrenergic neurons of the locus ceruleus recorded in vitro. The Journal of
neuroscience : the official journal of the Society for Neuroscience 24 (43): 97039713.
Ji Y, Murphy AZ, Traub RJ (2006). Sex differences in morphine-induced analgesia of
visceral pain are supraspinally and peripherally mediated. American journal of
physiology Regulatory, integrative and comparative physiology 291 (2): R307314.
Kepler KL, Standifer KM, Paul D, Kest B, Pasternak GW, Bodnar RJ (1991). Gender
effects and central opioid analgesia. Pain 45 (1): 87-94.
Kessler RC, McGonagle KA, Nelson CB, Hughes M, Swartz M, Blazer DG (1994). Sex
and depression in the National Comorbidity Survey. II: Cohort effects. Journal of
affective disorders 30 (1): 15-26.
Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995). Posttraumatic stress
disorder in the National Comorbidity Survey. Archives of general psychiatry 52
(12): 1048-1060.
Kest B, Palmese C, Hopkins E (2000a). A comparison of morphine analgesic tolerance in
male and female mice. Brain research 879 (1-2): 17-22.
Kest B, Sarton E, Dahan A (2000b). Gender differences in opioid-mediated analgesia:
animal and human studies. Anesthesiology 93 (2): 539-547.

	
  

23	
  

Kreibich A, Reyes BA, Curtis AL, Ecke L, Chavkin C, Van Bockstaele EJ, et al (2008).
Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate
receptors: a novel mechanism for regulating the central norepinephrine system.
The Journal of neuroscience : the official journal of the Society for Neuroscience
28 (25): 6516-6525.
Li HY, Ericsson A, Sawchenko PE (1996). Distinct mechanisms underlie activation of
hypothalamic neurosecretory neurons and their medullary catecholaminergic
afferents in categorically different stress paradigms. Proceedings of the National
Academy of Sciences of the United States of America 93 (6): 2359-2364.
Mansour A, Fox CA, Thompson RC, Akil H, Watson SJ (1994). mu-Opioid receptor
mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain
research 643 (1-2): 245-265.
Milner TA, Burstein SR, Marrone GF, Khalid S, Gonzalez AD, Williams TJ, et al (2013).
Stress differentially alters mu opioid receptor density and trafficking in
parvalbumin-containing interneurons in the female and male rat hippocampus.
Synapse (New York, NY) 67 (11): 757-772.
Moore RY, Bloom FE (1979). Central catecholamine neuron systems: anatomy and
physiology of the norepinephrine and epinephrine systems. Annual review of
neuroscience 2: 113-168.
Page ME, Abercrombie ED (1999). Discrete local application of corticotropin-releasing
factor increases locus coeruleus discharge and extracellular norepinephrine in rat
hippocampus. Synapse (New York, NY) 33 (4): 304-313.

	
  

24	
  

Pert CB, Snyder SH (1976). Opiate receptor binding--enhancement by opiate
administration in vivo. Biochemical pharmacology 25 (7): 847-853.
Reyes BA, Glaser JD, Van Bockstaele EJ (2007). Ultrastructural evidence for colocalization of corticotropin-releasing factor receptor and mu-opioid receptor in
the rat nucleus locus coeruleus. Neuroscience letters 413 (3): 216-221.
Reyes BA, Valentino RJ, Xu G, Van Bockstaele EJ (2005). Hypothalamic projections to
locus coeruleus neurons in rat brain. The European journal of neuroscience 22
(1): 93-106.
Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, et al (1996).
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin
releasing factor receptors. Proceedings of the National Academy of Sciences of the
United States of America 93 (19): 10477-10482.
Snyder K, Wang WW, Han R, McFadden K, Valentino RJ (2012). Corticotropinreleasing factor in the norepinephrine nucleus, locus coeruleus, facilitates
behavioral flexibility. Neuropsychopharmacology : official publication of the
American College of Neuropsychopharmacology 37 (2): 520-530.
Soldin OP, Chung SH, Mattison DR (2011). Sex differences in drug disposition. Journal
of biomedicine & biotechnology 2011: 187103.
Swanson LW (1976). The locus coeruleus: a cytoarchitectonic, Golgi and
immunohistochemical study in the albino rat. Brain research 110 (1): 39-56.
Swanson LW, Hartman BK (1975). The central adrenergic system. An
immunofluorescence study of the location of cell bodies and their efferent

	
  

25	
  

connections in the rat utilizing dopamine-beta-hydroxylase as a marker. The
Journal of comparative neurology 163 (4): 467-505.
Tjoumakaris SI, Rudoy C, Peoples J, Valentino RJ, Van Bockstaele EJ (2003). Cellular
interactions between axon terminals containing endogenous opioid peptides or
corticotropin-releasing factor in the rat locus coeruleus and surrounding dorsal
pontine tegmentum. The Journal of comparative neurology 466 (4): 445-456.
Vale W, Spiess J, Rivier C, Rivier J (1981). Characterization of a 41-residue ovine
hypothalamic peptide that stimulates secretion of corticotropin and betaendorphin. Science (New York, NY) 213 (4514): 1394-1397.
Valentino RJ, Chen S, Zhu Y, Aston-Jones G (1996). Evidence for divergent projections
to the brain noradrenergic system and the spinal parasympathetic system from
Barrington's nucleus. Brain research 732 (1-2): 1-15.
Valentino RJ, Foote SL (1987). Corticotropin-releasing factor disrupts sensory responses
of brain noradrenergic neurons. Neuroendocrinology 45 (1): 28-36.
Valentino RJ, Foote SL, Aston-Jones G (1983). Corticotropin-releasing factor activates
noradrenergic neurons of the locus coeruleus. Brain research 270 (2): 363-367.
Valentino RJ, Page M, Van Bockstaele E, Aston-Jones G (1992). Corticotropin-releasing
factor innervation of the locus coeruleus region: distribution of fibers and sources
of input. Neuroscience 48 (3): 689-705.
Valentino RJ, Van Bockstaele E (2008). Convergent regulation of locus coeruleus
activity as an adaptive response to stress. European journal of pharmacology 583
(2-3): 194-203.

	
  

26	
  

Valentino RJ, Van Bockstaele E (2015). Endogenous opioids: The downside of opposing
stress. Neurobiology of Stress 1: 23-32.
Valentino RJ, Wehby RG (1988). Corticotropin-releasing factor: evidence for a
neurotransmitter role in the locus ceruleus during hemodynamic stress.
Neuroendocrinology 48 (6): 674-677.
Van Bockstaele EJ, Branchereau P, Pickel VM (1995). Morphologically heterogeneous
met-enkephalin terminals form synapses with tyrosine hydroxylase-containing
dendrites in the rat nucleus locus coeruleus. The Journal of comparative
neurology 363 (3): 423-438.
Van Bockstaele EJ, Colago EE, Valentino RJ (1996). Corticotropin-releasing factorcontaining axon terminals synapse onto catecholamine dendrites and may
presynaptically modulate other afferents in the rostral pole of the nucleus locus
coeruleus in the rat brain. The Journal of comparative neurology 364 (3): 523534.
Van Bockstaele EJ, Colago EE, Valentino RJ (1998). Amygdaloid corticotropin-releasing
factor targets locus coeruleus dendrites: substrate for the co-ordination of
emotional and cognitive limbs of the stress response. Journal of
neuroendocrinology 10 (10): 743-757.
Van Bockstaele EJ, Peoples J, Valentino RJ (1999). A.E. Bennett Research Award.
Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus
region by limbic afferents. Biological psychiatry 46 (10): 1352-1363.

	
  

27	
  

Wang X, Traub RJ, Murphy AZ (2006). Persistent pain model reveals sex difference in
morphine potency. American journal of physiology Regulatory, integrative and
comparative physiology 291 (2): R300-306.
Waterhouse BD, Lin CS, Burne RA, Woodward DJ (1983). The distribution of
neocortical projection neurons in the locus coeruleus. The Journal of comparative
neurology 217 (4): 418-431.
Weathington JM, Cooke BM (2012). Corticotropin-releasing factor receptor binding in
the amygdala changes across puberty in a sex-specific manner. Endocrinology
153 (12): 5701-5705.
Weissman MM, Klerman GL (1977). Sex differences and the epidemiology of
depression. Archives of general psychiatry 34 (1): 98-111.
Williams JT, North RA (1984). Opiate-receptor interactions on single locus coeruleus
neurones. Molecular pharmacology 26 (3): 489-497.
Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, et al (2000).
Pronounced and sustained central hypernoradrenergic function in major
depression with melancholic features: relation to hypercortisolism and
corticotropin-releasing hormone. Proceedings of the National Academy of
Sciences of the United States of America 97 (1): 325-330.
Xu GP, Van Bockstaele E, Reyes B, Bethea T, Valentino RJ (2004). Chronic morphine
sensitizes the brain norepinephrine system to corticotropin-releasing factor and
stress. The Journal of neuroscience : the official journal of the Society for
Neuroscience 24 (38): 8193-8197.

	
  

28	
  

CHAPTER 2: SEX DIFFERENCES IN µ-OPIOID RECEPTOR OF THE RAT
LOCUS COERULEUS AND THEIR COGNITIVE CONSEQUENCES
Abstract
Stress-related neuropsychiatric pathologies are more prevalent in females compared with
males. An important component of the stress response is activation of the locus coeruleus
(LC)–norepinephrine system. Because LC activation is tempered by endogenous opioid
release during stress, the magnitude of opioid regulation of the LC could determine stress
vulnerability. Here we report convergent evidence for decreased µ-opioid receptor
(MOR) function in the female rat LC. The selective MOR agonist, DAMGO (10 pg),
completely inhibited LC discharge of male but not female rats and DAMGO (30 pg)
produced no further inhibition of female LC neurons. Consistent with a decreased
maximum DAMGO response, MOR protein, and mRNA expression were decreased in
female compared with male LC. These molecular and cellular sex differences were
associated with sexually distinct effects of LC-MOR activation on cognitive processing
in an operant strategy-shifting task. Although DAMGO (10 pg intra-LC) increased the
number of trials to reach criterion for both sexes, it increased the duration to complete the
task and the total number of errors selectively in males. Specifically, DAMGO increased
premature responses, regressive errors, and random errors in males and perseverative
errors in females. The sexually distinct cognitive consequences of activating LC-MOR
may contribute to sex differences in opioid abuse patterns and may guide sex-specific
therapies. Finally, given evidence that endogenous opioids restrain stress-induced LC
activation and promote recovery of activity to pre-stress levels, decreased MOR function
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in the female LC could contribute to LC-NE over activity that underlies the hyperarousal
symptoms of stress-related psychiatric diseases.
Introduction
Many neuropsychiatric diseases such as post-traumatic stress disorder (PTSD),
and depression are nearly twice as prevalent in females compared to males (Kessler et al,
1994; Kessler et al, 1995). These diseases have been associated with stress, suggesting
that sex differences in prevalence arise from sex differences in stress response systems. In
addition to sharing an association with stress, these disorders share symptoms of
hyperarousal, implicating a common defect in arousal systems. The locus coeruleusnorepinephrine (LC-NE) system is a major brain arousal system that is activated by
stressors, and LC hyperactivity has been implicated in the altered arousal that
characterizes stress-related psychiatric disorders (Wong et al, 2000). Therefore, the LCNE system is a site at which sex differences could be translated to differential
vulnerability to stress-related psychiatric disorders.
The LC is the principal source of norepinephrine in many forebrain regions that
underlie cognition such as the cortex and the hippocampus (Swanson, 1976). During
acute stress, LC neurons are activated by the stress-related neuropeptide, corticotropinreleasing factor (CRF), and this is associated with enhanced arousal and cognitive
flexibility (Snyder et al, 2012; Valentino et al, 2008). Interestingly, CRF antagonist
administration prior to acute stress not only prevents LC activation but also reveals an
underlying inhibition of LC neurons that is opioid-mediated (Curtis et al, 2001; Curtis et
al, 2012). Axon terminals containing the endogenous opioid, enkephalin, densely
innervate the LC, and LC neurons express µ-opioid receptors (MOR; (Drolet et al, 1992;
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Pert et al, 1976a). MOR activation robustly inhibits LC discharge (Williams et al, 1984).
Under basal conditions, opioid antagonists do not alter LC discharge, indicating that
endogenous opioids are not tonically released into the LC. However, when administered
prior to acute stress, opioid antagonists increase LC activation and prolong recovery time
after stressor termination, suggesting that endogenous opioids in the LC function to
restrain stress-induced activation, and to promote recovery of neuronal firing to baseline
levels when the stressor is terminated (Abercrombie and Jacobs, 1988a; Curtis et al,
2001; Curtis et al, 2012). Given the role of CRF in mediating stress-induced LC
activation, sex differences in CRF signaling and trafficking in LC neurons (Bangasser et
al, 2010) has been proposed as one mechanism underlying LC-NE dysregulation, and
contributes to female vulnerability to stress-related psychiatric disorders. An additional
mechanism by which the LC-NE system could become dysregulated is through decreased
opioid inhibition. Consistent with this, analgesic studies in both humans and rodents
provide evidence for decreased opioid sensitivity of females (Craft, 2003; Kest et al,
2000b). On the basis of these observations, this study was designed to compare the
neuronal and behavioral consequences of MOR activation in the LC of male and female
rats. In addition, MOR protein and mRNA expression in the LC were compared.
Materials and Methods
Subjects. Age-matched adult male and female Sprague Dawley rats (Charles
River, Wilmington, MA) were shipped from the vendor at ~70 days of age. Experiments
were conducted 1 week after arrival. Rats were singly housed in a climate controlled
room with a 12-h light–dark cycle (lights on at 0700 hours). Food and water were freely
available except as noted for behavioral experiments. Female rats were intact. Animal use
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and care was approved by the institutional animal care and use committee of the
Children’s Hospital of Philadelphia.
Electrophysiological Studies. Surgical and electrophysiological recording
protocols were similar to those described previously (Curtis et al, 1997), (Supplementary
Information). Rats were anesthetized with isofluorane and surgically prepared for
recording LC single unit discharge. Double-barrel glass micropipettes were used for
simultaneous recording and microinfusion of DAMGO ([D-Ala2, N-MePhe4, Gly-ol]enkephalin; Abcam, Cambridge, MA), a synthetic opioid peptide with high MOR
specificity. LC activity was recorded before and after DAMGO administration
(Supplementary Information). The effects of different DAMGO doses were compared
between sexes using a two-way repeated measure ANOVA with time as the repeated
measure. In addition, the area under the time-effect curve (0–300s after injection) for the
10 pg dose was calculated and compared between sexes using a Student’s t-test (two
tailed).
Western Blotting. Male and female rats were decapitated and brains quickly
removed and frozen. Thick (1000µm) coronal sections containing the LC were cut on a
cryostat and LC tissue punches were taken from these sections using a trephine. The
tissue was processed for protein analysis by western blot as described (Curtis et al, 2006)
(Supplementary Information). Membranes were probed for MOR and β-actin (1:1000
rabbit anti-MOR, Invitrogen and 1:5000 mouse anti-β-actin, Sigma) as previously
described (Bangasser et al (2010); Supplementary Information). The ratio of target
protein (MOR) to loading control (β-actin) was calculated, and the mean ratios were
statistically compared using an ANOVA. Characterization and specificity of the rabbit
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MOR antiserum have been described (Cheng et al, 1996; Surratt et al, 1994; Van
Bockstaele et al, 1996a). In addition, MOR antibody specificity was tested by probing rat
heart lysates, which do not express MOR (Peng et al, 2012; Ventura et al, 1989)
(Supplementary Figure 7).
Quantitative PCR Analysis of MOR mRNA. LC punches were collected as
described above. LC tissue was lysed and homogenized according to manufacturer’s
instructions in the PureLink RNA mini kit (AMBION, Life Technologies; Supplementary
Information). Real-time PCR was performed using TaqMan gene expression assays with
TaqMan universal PCR master mix (Applied Biosystems, Foster City, CA). Assays
utilized were MOR (Oprm1, Rn01430371_m1) and GAPDH (Gapdh, Rn01775763_g1).
Gene expression analysis was performed using the comparative CT (cycle threshold)
method as described (Schmittgen and Livak, 2008). An ANOVA was used for sex
comparisons.
Operant Strategy Shifting Assay. Male and female rats were implanted with a
dual cannula guide (Plastic One Inc, Roanoke VA) for bilateral LC injections as
previously described (Snyder et al, 2012). At least 4 days after surgery and 3 days prior
to the start of training, rats were food restricted to 85% of their weight. Rats were trained
and tested in an Operant Strategy Set Shifting Task (OSST) that was a modification of
Floresco et al (2008) as previously described (Snyder et al, 2015); Supplementary
Information). Rats were first trained to press one of two levers for food reinforcement on
the first training day, and the opposite lever on the following day. On the third training
day, stimulus lights that were located above both levers were illuminated for 15 seconds
during which levers were randomly selected to deliver reward, and over many trials both
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levers were equally likely to deliver a reward. Tests were conducted the following day
during which rats received bilateral intra-LC microinfusions of either ACSF or DAMGO
(3, 10 pg in 200 nl) delivered by a syringe pump 10 minutes prior to behavioral testing.
The OSST has three stages that involve different forms of learning, a simple
discrimination (SD), reversal learning (REV), and strategy shifting (SHIFT). Animals
proceeded from one stage of the task to the next stage after achieving a criterion of eight
consecutive correct presses, provided that at least 30 trials had been attempted. The
minimum of 30 trials requirement ensured that each animal experienced sufficient trials
for the transition from one type of discrimination to the next, and to ensure it was
cognitively meaningful. During testing for all stages, only one of the stimulus lights
above the levers was randomly illuminated. During the SD stage, reward was contingent
on lever presses on the side opposite of the animal’s side bias (determined during
training), and the location of the stimulus light was unrelated to the contingency. During
the REV stage, reward was contingent on lever presses on the opposite lever. During the
SHIFT stage, the correct lever was designated as the lever underneath the illuminated
stimulus light. Upon reaching the criterion of eight consecutive correct presses in the
SHIFT stage, the test ended and the animal was removed from the testing chamber. Dye
was infused through the cannulae for histological identification of injection sites. Trials
to criterion were recorded during each stage of the OSST. Error types within the shift to
light stage of the OSST were characterized using logistic regression in order to determine
whether treatments had an effect on the perseveration of the previous rule or the
acquisition and maintenance of the new rule (Snyder et al (2015); Supplementary
Information). Errors of omission and premature responses that occurred during the inter-
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trial interval were also calculated and the numbers of all total errors (perseverative,
regressive, random, omission, and premature responses) were compared between groups.
In addition, the duration to complete the strategy shifting stage and mean correct and
incorrect response latencies for rats administered ACSF or DAMGO (10pg) were
compared.
OSST Statistical Analysis. OSST data (trials to reach criterion) were first
analyzed using a three-factor repeated measures ANOVA with dose and sex as between
factors, and stage as the repeated measure. Each stage was then analyzed separately by a
two-factor ANOVA to determine effects of dose, sex, and dose X sex interactions for
each individual stage (SD, REV, and SHIFT). The Tukey’s HSD test was used post hoc
to determine statistically significant differences between individual sex/dose groups.
Total errors, error type, duration to complete the strategy shifting stage, and correct and
incorrect response latencies were analyzed by a two-factor ANOVA with dose and sex as
factors. To analyze regional specificity, the effect of accurate vs inaccurate DAMGO (3
pg) injections and injections of ACSF on each stage of the set shifting task were analyzed
for each sex individually using one way ANOVAs with Tukey’s HSD post hoc for
individual comparisons. An alpha level of po0.05 was the maximum threshold for
statistical significance. The 3 pg dose was chosen for this analysis rather than the 10 pg
dose because there were an insufficient number of inaccurate injections in the 10pg group
to provide sufficient power for the statistical comparison of that dose group.
Estrous Cycle Monitoring. It was not the goal of this study to determine the role
of gonadal hormones in MOR regulation of the LC; however, for electrophysiological
studies, qPCR, and behavioral studies estrous cycle status was monitored by vaginal
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cytology as previously described (Bangasser and Shors, 2008). For these studies, females
were subdivided into those in relatively high (proestrus) or relatively low (estrus and
diestrus pooled) estrus states, and the DAMGO effect determined in these specific
groups.
Results
Decreased Sensitivity of Female LC Neurons to MOR–mediated Inhibition
LC spontaneous discharge rates were comparable between males (2.10±0.2Hz,
n=20cells/14 rats) and females (1.74±0.22Hz, n=26 cells/18 rats; F (1, 44) =1.4, p>0.05).
Figures 3a and 3b show the time-course of the mean LC activity (expressed as a
percentage of the baseline rate) before, during, and after DAMGO (0.1, 1, and 10 pg)
microinfusion. No sex differences were found in the response to DAMGO (0.1 pg; F (1,
68) =0.27, p=0.60) or DAMGO (1 pg; F (1, 99) =0.49, p=0.49). Notably, the 10 pg
DAMGO dose completely suppressed LC firing in male but not female rats (Figures 3c
and 3d). The mean inhibition of LC discharge rate produced by this DAMGO dose was
different in males and females (F (1, 12) =15.281, p<0.002). To determine whether a
higher dose of DAMGO could completely inhibit LC neurons of female rats, (30 pg, 10
cells/ 6 rats) DAMGO was tested. The magnitude of inhibition produced by this dose in
females was similar to that produced by the 10 pg DAMGO dose in females (F (1, 15)
=0.088, p=0.77) and less than that produced by the 10 pg DAMGO dose in males (F (1,
15) =4.30, p<0.047; Figure 3b). The sex difference was also apparent as a decreased area
under the curve describing the effect over time (males: 23017±1105 vs females:
15837±1541; p=0.005, Student’s t-test two tailed). The decreased effect of high doses of
DAMGO on LC neuronal activity was true for both female rats in diestrus/estrus and
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those in proestrus (Supplementary Figure 8). For this comparison, because most cells
tested with DAMGO (10 pg) came from female rats in proestrus, data from these were
pooled with cells from female rats tested with 30 pg DAMGO, which had a similar effect
as 10 pg DAMGO in females and remained less than that produced by 10 pg in males
(Supplementary Figure 8).
Decreased MOR Expression in Female LC
The decreased maximum inhibition of LC activity produced by DAMGO in
females suggested differences in MOR expression. Consistent with this, quantification of
MOR protein in the LC using Western blot indicated lower levels in females (Figure 4).
Figure 4a shows a representative western blot of MOR (green) and β-actin (red). The
mean MOR: β-actin ratio was greater in male rats when compared to female rats (F (1,
20) =4.5, p=0.045; each group n=11; Figure 4b). To determine whether sex differences in
LC-MOR levels were related to differences in LC-MOR transcription, qPCR was used to
quantify and compare MOR mRNA in the LC. Consistent with the Western blot analysis,
the qPCR analysis revealed decreased levels of LC-MOR transcripts in females when
compared with males (F (1, 26) =4.87, p=0.036; n=14 both groups; Figure 4c). Levels of
transcripts were comparable in females that were in an estrus cycle stage of high estrogen
(proestrus, 0.62 ± 0.17), or relatively low estrogen (diestrus or estrus pooled, 0.72 ± 0.17,
p=0.71; Supplementary Figure 9).
Sex Differences in the Behavioral Consequences of MOR Activation in the LC
A total of 52 rats were implanted with dual intra-LC cannula and completed all
stages of the OSST. Figure 5 shows the mean number of trials to reach the criterion for
each stage of the task for males (Figure 5a) and females (Figure 5b) administered
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DAMGO or vehicle. A three-factor ANOVA to test for main effects of dose and sex with
stage as the within-subject factor revealed a main effect of the whole model (F (5,
46)=5.3, p<0.0006), an effect of dose (F (2, 46)=11.4, p<0.001), an effect of stage (F (2,
45)=46.5, p<0.0001), dose X stage interaction (F (4, 90)=6.9, p<0.001), and a trend for
stage X sex X dose interaction (F (4, 90)=2.4, p<0.055) for trials to reach criterion
(Figures 5a and 5b). Further analysis of individual stages revealed a trend for a main
effect in SD (F (5, 51) =2.03, p=0.09), and a trend for a sex X dose interaction (F=3.2,
p=0.051) such that DAMGO tended to facilitate SD performance in male rats. However,
Tukey’s HSD post-hoc test did not indicate group differences. There was no main effect
on REV (F (5, 51) =1.18, p=0.33). Analysis of behavior during the SHIFT stage revealed
a main effect of the whole model (F (5, 51) =6.03, p<0.0002), and an effect of dose
(F=13.5, p<0.0001) such that 3 pg and 10 pg DAMGO increased the number of trials to
reach criterion. There was no significant sex X dose interaction (F=2.1, p=0.14). An
examination of behavioral results broken down into proestrus and estrus/diestrus groups
suggested that results were comparable regardless of estrus status (Supplementary Figure
10).
Although there was no sex difference in the number of trials to reach criterion for
the strategy-shifting task, male rats took significantly longer to complete this stage after
DAMGO (10 pg) (Table 1). Specifically, there was a significant main effect (F (3, 33)
=3.97, p=0.017), an effect of dose (F=8.4, p<0.006), and sex X dose interaction (F=4.8,
p<0.03; p<0.05, Tukey’s HSD). This was not likely the result of decreased motivation
because there was no sex difference in the duration to complete the reversal stage.
Females administered ACSF or DAMGO (10 pg) took 1135 ± 162 sec and 1334 ± 247
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sec, respectively to complete the REV stage and males took 1050 ± 202 sec and 1202 ±
271 sec after ACSF and DAMGO (10 pg), respectively (F (3, 33) =0.28, p=0.8). The
increased duration for males to complete the task was also not due to increased response
latency as this was unaffected by dose and was comparable between sexes (Table 1).
Rather, males made more total errors (F (3, 33) =6.7, p<0.005; Figures 5c and 5d). There
was an effect of dose on total errors (F (1, 33) =15.8, p<0.0005), and a sex X dose
interaction (F (1, 33) =5.5, p<0.02) indicating that DAMGO (10 pg) increased total errors
selectively for males. A detailed analysis of error type indicated that the number of
omitted trials was comparable between males and females (F (3, 33) =1.3, p=0.29;
Figures 5e and 5f). DAMGO (10 pg) increased premature responding (Main effect: F (3,
33) =5.9, p<0.005, dose effect: F (1, 33) =13.5, p<0.001) and there was a trend for a sex
X dose interaction: F (1, 33) =3.3, p=0.07). A Tukey’s HSD post-hoc test indicated that
compared with vehicle, DAMGO (10 pg) increased premature responses in males and not
females (p<0.05 Tukey’s HSD; Figures 5c and 5d). DAMGO (10 pg) also promoted
different error types during the SHIFT trials depending on sex. For males, DAMGO (10
pg) increased regressive and random errors (Figure 5e). There was a main effect of
treatment for regressive errors (F (3, 33) =4.7 p<0.01), and a sex X dose interaction (F (1,
33) =11.4, p<0.005). Likewise, for random errors, there was a main effect of treatment (F
(3, 33) =3.3 p<0.05) and a sex X dose interaction (F=6.7, p<0.05) such that DAMGO
increased regressive and random errors selectively in male rats when compared with
vehicle control (p<0.05, Tukey’s HSD, both error types). In contrast, DAMGO (10 pg)
increased perseverative errors in females (Figure 5f). There was a significant main effect
of treatment (F (3, 33) =8.7 p=0.0003) and a sex X dose interaction (F=6.8, p<0.05) such
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that 10 pg DAMGO increased perseverative errors selectively in female rats when
compared with vehicle control (p<0.05, Tukey’s HSD).
Regional Specificity
The behavioral effects of DAMGO were regionally localized to the LC. Figure 6a
shows representative histology of an accurate bilateral injection into the LC in a rat that
was administered 3 pg DAMGO. Because most of the 10 pg DAMGO injections were
accurate (Supplementary Figure 11), only the effects of accurate vs inaccurate injections
of the 3 pg dose were statistically compared (Figures 6b–6d). DAMGO injections outside
of the LC had no effect on performance in any task stage for either males or females
(Figures 6c and 6d). For males there was an effect of placement on SD performance (F
(2, 21)=6.9, p<0.01) and SHIFT performance (F (2, 21)=8.5, p<0.005). Post hoc
comparisons revealed that only rats that received accurate injections were impaired
compared with the ACSF group (p<0.05, Tukey’s HSD; Figure 6c). Likewise, only
female rats administered DAMGO (3 pg) into the LC required a greater number of trials
to reach criterion during the SHIFT stage compared with females administered ACSF (F
(2, 28) =4.2, p<0.05, p<0.05 Tukey’s HSD test; Figure 6d).
Discussion
The present study provided convergent cellular, molecular, and behavioral
evidence for decreased MOR function in the LC of female compared with male rats. At a
cellular level, postsynaptic responses of LC neurons to relatively high DAMGO doses
were attenuated in female compared with male rats. Consistent with a decreased
maximum response to a MOR agonist, quantification of MOR protein and mRNA in LC
tissue indicated decreased MOR expression in female compared with male LC tissue.
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Notably, these molecular and cellular sex differences were associated with sexually
distinct behavioral consequences of LC-MOR activation. Thus, a DAMGO dose that
completely inhibited LC neuronal activity of male but not female rats significantly
increased the time to complete the strategy shifting stage selectively in males as a result
of increasing the total number of errors. DAMGO produced sexually distinct cognitive
effects that were expressed as differences in error types during strategy shifting
performance. Sex differences in the effects of LC-MOR activation on cognitive
processing may be relevant for sex differences in opioid abuse. The findings agree with
evidence for decreased MOR function in females from analgesia and receptor signaling
studies (Craft, 2003; Kest et al, 2000b; Wang et al, 2014). Given the evidence for an
inhibitory influence of endogenous opioids in the LC that restrains stress-induced LC
activation and promotes recovery of LC activity to pre-stress levels, the decreased MOR
function in the female LC could contribute to LC-NE over activity that underlies
hyperarousal symptoms of stress related psychiatric diseases (Gold et al, 2002; Wong et
al, 2000). This may have a role in the greater prevalence of stress-related psychiatric
disorders in females.
Sex Differences in LC Neuronal Responses to MOR Activation
Anatomical and physiological evidence implicate the enkephalin-MOR system as
an important inhibitory regulator of LC activity (Drolet et al, 1992; Pert et al, 1976a;
Williams et al, 1984). This regulation is not tonically active because opioid antagonists
do not alter LC spontaneous discharge rates (Abercrombie et al, 1988a; Valentino et al,
1989). Rather, it becomes engaged during acute stress where it functions to counter LC
activation and promote recovery with stressor termination (Curtis et al, 2001; Curtis et al,
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2012). Identification of individual differences in MOR regulation of the LC is therefore
important as this can determine the magnitude and duration of the LC-NE response to
stress. Human and rodent studies report a decreased sensitivity of females to opioidinduced analgesia, behavioral suppression, tolerance, and dependence (Craft, 2003; Kest
et al, 2000b). This has been attributed in part to decreased MOR expression and MOR-Gprotein coupling (Loyd et al, 2008; Murphy et al, 2009; Wang et al, 2014). However,
these sex differences are regionally specific and there have been no studies of sex
differences in MOR in the LC. As previously reported, there were no sex differences in
baseline LC spontaneous discharge rate (Curtis et al, 2006). Although DAMGO produced
the characteristic LC inhibition in both sexes, the maximum magnitude of inhibition was
significantly less in females, even when the dose was increased beyond that which
completely inhibited male LC neurons. The decreased maximal effect suggests decreased
LC-MOR levels in the female rather than a decrease in agonist affinity.
Molecular Basis for Sex Differences in LC Post-synaptic Responses to a MOR
Agonist
Protein quantification by western blot confirmed decreased MOR protein in the
LC of female compared with male rats. The interpretation of this finding relies on the
specificity of the MOR antibody. Characterization and specificity of the rabbit antiserum
against the MOR protein have been described previously (Cheng et al, 1996; Surratt et al,
1994; Van Bockstaele et al, 1996b). In addition, antibody specificity was tested using
heart tissue, which does not express MOR protein (Peng et al, 2012; Ventura et al, 1989)
(Supplementary Figure 7). Decreased MOR expression in female compared with male
rats has been documented in other brain regions including the periaqueductal gray (Loyd
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et al, 2008), and the rat anterior pituitary gland (Carretero et al, 2004). Quantitative PCR
corroborated the interpretations of the western blot studies and suggested that decreased
MOR transcription underlies decreased MOR protein.
Sex Differences in Behavioral/Cognitive Endpoints of MOR Activation in the LC
Importantly, sex differences in MOR expression and cellular function in the LC
were reflected as differences in the behavioral consequences of LC-MOR activation. The
LC regulates cognitive flexibility through its projections to the prefrontal cortex (PFC).
The relationship between LC activity and PFC function is hypothesized to resemble an
inverted U-shaped curve whereby PFC function is optimal at moderate levels of LC
activity. However, excessive LC drive impairs cognitive flexibility as a result of the
interaction of higher levels of norepinephrine with lower-affinity adrenergic receptors
(Arnsten, 2011). CRF, at doses that produce a moderate activation of LC neurons,
facilitates cognitive flexibility in an attentional set-shifting task. However, this effect
reverses as the CRF dose is increased (Snyder et al, 2012). Because stress also engages
enkephalin release in the LC, which could counter the effects of CRF, it is important to
understand how this could impact cognitive flexibility. Our electrophysiological and
molecular findings predicted an enhanced behavioral response to relatively high doses of
DAMGO in the LC in males compared with females, particularly in the strategy shifting
stage. Although the highest DAMGO dose had similar effects on the number of trials to
reach criterion in this stage, males took significantly more time to complete this stage.
The increased duration could not be attributed to an increase in response latency once a
trial started or solely to trial omissions. Rather, this was due to an increase in total errors
made by males and particularly premature responses, which are indicative of impulsive
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behavior. This is consistent with reports of opioid elicited impulsive behavior in rodents
in behavioral tasks such as the 5-choice serial response time task (5-CSRTT), the
response inhibition task, and the decrease in motor impulsivity in MOR-knockout mice
(Mahoney et al, 2013; Olmstead et al, 2009; Pattij et al, 2009). As these previous studies
examined only males, the present findings suggest that this may be a male-biased effect
that involves the LC norepinephrine system.
In addition to increases in premature responding, DAMGO (10 pg) also increased
regressive and random errors selectively in males, indicative of an inability to acquire and
maintain the new strategy (Floresco et al, 2008). In contrast, females administered
DAMGO made more perseverative errors, which are indicative of an impaired ability to
shift from a previously learned rule. Taken together with evidence for decreased LCMOR receptor expression and physiological function, the data suggests that the ability to
shift from a previously learned rule may be more sensitive to disruption by LC-MOR
activation than facilitation of impulsive behavior, or impairment in the ability to learn a
new strategy, which may require greater LC-MOR occupancy and LC inhibition.
Implications
The present findings suggest that the ability of endogenous opioids to buffer LC
activation during stress, and to promote recovery would be less effective in females. A
decreased opioid influence in the LC in females would converge with increased CRF
receptor signaling to produce an enhanced arousal response to stressors that could
contribute to a greater prevalence of stress-related psychiatric disorders in females.
Several studies provide evidence that the effects of endogenous opioids released during
stress are attenuated in females compared with males. For example, stress-induced
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opioid-mediated analgesia (Kavaliers and Innes, 1987; Mogil et al, 1993; Romero and
Bodnar, 1986), naloxone-induced freezing after stress (Klein et al, 1998) and naloxoneprecipitated withdrawal in rats with a history of stress (Klein et al, 1997) are all greater in
males compared with females. The results also have implications for the treatment of
post-traumatic stress disorder (PTSD). Morphine administration during trauma care is
associated with a decreased incidence of PTSD, particularly the arousal symptom cluster
(Bryant et al, 2009; Holbrook et al, 2010; Stoddard et al, 2009). The present findings
predict that this course of treatment would be less effective in females. Finally, sexspecific effects of LC-MOR activation on cognitive processing are relevant for
understanding sex differences in opioid abuse, and for designing sex-specific treatments.
The greater promotion of impulsive behavior in males may facilitate an earlier onset of
abuse. The high rate of perseverative responding in females suggests that once the cycle
of opioids abuse begins, it may be more difficult to reverse in females. This is consistent
with the findings that once initiated, substance abuse accelerates at a faster pace in
females compared with males, craving is more severe, and it is more difficult to quit
(Back et al, 2011; Becker and Hu, 2008). The present findings underscore the potential
for sex specific treatment of opioid abuse based on pharmacological and/or cognitive
therapies that target different cognitive dimensions.
Funding and Disclosure
This work was supported by PHS grants DA09082 (RJV), T32MH017168 Training
Program in Behavioral and Cognitive Neuroscience (HMG), and F31MH10521 NIMH
NRSA for Individual Predoctoral Fellowships (HMG). The authors declare no conflict of
interest.

	
  

45	
  

Acknowledgments
We acknowledge the technical assistance of Xiao-Yan Zhang, and Rosa Chen.

	
  

46	
  

Figures and Legends

	
  

Figure 3. Dose-related inhibition of locus coeruleus (LC) neuronal discharge rate by
DAMGO (D-Ala2, N-MePhe4, Gly-ol]-enkephalin) in male and female rats.
(A and B) Line graphs show the time course of DAMGO effects on LC discharge rate.
The abscissae indicate time (s) before and after DAMGO, which was administered at
time=0. The ordinates indicate LC discharge rate expressed as a percentage of the
baseline rate before DAMGO. For 0.1 pg: males (n=6 cells/3 rats), females (n=3 cells/3
rats); for 1 pg: males (n=7 cells/6 rats), females (n=6 cells/4 rats); for 10 pg: males (n=7
cells/5 rats), females (n=7 cells/5 rats); for 30 pg females (n=10 cells/6 rats). (C and D)
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Representative ratemeter records from a single locus coeruleus neuron of a (C) male and
(D) female rat before and after DAMGO 10 pg microinfusion into the LC (indicated by
the bars above the traces).
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Figure 4. Sex differences in locus coeruleus-µ-opioid receptor (LC-MOR) protein
and mRNA.
(A) Blots represent the MOR protein band (green) and β-actin band (red) as a loading
control of LC-tissue punches from male (M) and female (F) rats. Note that the contrast
was increased selectively around the molecular weight ladder to be able to visualize it.
(B) Bars indicate the mean ratio of the integrated intensity of each band of MOR protein
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to the corresponding band of β-Actin as loading control from the same samples (n=11,
each group). (C) Bars indicate relative quantification (RQ) of the MOR gene in the LC.
Data are represented as the mean ± SEM ;( n=14, each group). GAPDH was used as an
endogenous control. *p<0.05.
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Figure 5. Sex differences in behavioral consequences of activating µ-opioid receptor
(MOR) in the locus coeruleus (LC).
(A and B) Effects of ACSF and DAMGO (D-Ala2, N-MePhe4, Gly-ol]-enkephalin; 3 pg
and 10 pg) bilaterally infused into the LC of male (A) and female (B) rats on performance

	
  

51	
  

in the operant strategy set-shifting task. The bars represent the mean number of trials
necessary to reach the criterion for side discrimination, side reversal, and shift to light
stages of the task. Vertical lines represent SEM. The number of subjects is indicated in
the graph legend. Asterisks above the bars indicate that both DAMGO doses were
associated with increased trials to reach criterion compared to ACSF (p<0.05). (C and D)
The bars represent the mean number of total errors and mean number of premature
responses in male (C) and female (D) rats administered ACSF or DAMGO (10 pg).
Asterisks indicate an effect of DAMGO over ACSF for the same sex (p<0.05, Tukey’s
HSD). (E and F) Analysis of error types in the shift stage in male (E) and female (F) rats.
The bars indicate the mean number of each error type. Vertical lines represent SEM.
Asterisks indicate a significant effect of DAMGO compared with ACSF for the same sex
group (p<0.05, Tukey’s HSD). #p=0.05 (Tukey’s HSD) compared with effect of
DAMGO in females.
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Figure 6. Regional specificity of DAMGO (D-Ala2, N-MePhe4, Gly-ol]-enkephalin)

	
  

effects on strategy shifting.
(A) Photomicrograph of a Neutral Red counterstained section through the LC showing
histological verification of the injection site from a representative animal that was
injected with DAMGO. The arrowhead points to the LC and the arrow points to the dye,
which is localized to the LC (Cb, cerebellum; V, ventricle). (B) Plots of accurate (circles)
and missed (squares) injection sites for DAMGO (3 pg) for males (black) and females
(red). DAMGO effects from these cases were used for the graphs in C and D. (C)
Comparison of the effects of DAMGO (3 pg) microinfused into the LC of male rats (in,
n=8), outside of the LC (out, n=5), and ACSF (n=9) on performance in different
components of the OSST. The bars indicate the number of trials necessary to reach the
criterion for each stage. Vertical lines represent SEM. Asterisks indicate a significant

	
  

53	
  

difference compared with both the ACSF and DAMGO out groups (p<0.05). (D)
Comparison of the effects of DAMGO (3 pg) microinfused into the LC of female rats (in,
n=10), outside of the locus coeruleus (LC; out, n=5) and ACSF (n=14) on performance in
different components of the OSST. The bars indicate the number of trials necessary to
reach the criterion for each stage. Vertical lines represent SEM. #p<0.05 compared with
ACSF.
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Table 1. Effects of DAMGO on the Duration to Complete the SHIFT Stage of the Task
and Response Latencies
Sex

Treatment

Duration (s)

Correct
Response
Latency (s)

Incorrect
Response Latency
(s)

Male (9)

ACSF

1358+206

4.5+0.5

3.7+0.36

Male (5)

DAMGO

4112+859*

4.3+0.3

3.1+0.2

Female (14)

ACSF

2444+468

4.7+0.3

3.9+0.3

Female (6)

DAMGO

2834+458

4.4+0.3

3.4+0.2

For stage duration: main effect: F (3, 33) =4.0, p<0.02, Treatment effect: F (1, 33) =8.4,
p<0.01, sex X treatment interaction: F (1, 33) =4.8, *p<0.05; p<0.05 Tukey’s HSD Male
DAMGO>Male ACSF.
For correct response latency: main effect: F (3, 33) =0.15, p=0.93.
For incorrect response latency: main effect: F (3, 33) =0.68, p=0.57.
The bold value highlights that this is significantly different from the ACSF control.
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Supplemental Information
Supplemental Methods
Electrophysiological Studies. Rats were anesthetized with a 2% isoflurane-in-air
mixture administered through a nose cone and positioned in a stereotaxic instrument.
Anesthesia was maintained at 1.0-1.5% throughout the experiment and body temperature
was maintained at 37.5 C by a feedback controlled heating pad. Animals were positioned
in a sterotaxic instrument and a craniotomy was performed 1.2 mm lateral to the midline
and 3.6 mm caudal to lambda. The recording glass micropipette (2-4 um diameter tip, 4-7
Ohm) was filled with 0.5 M sodium acetate buffer saturated with 2% pontamine sky blue
dye (PSB). The microinfusion pipette (60-90 um diameter tip) was angled at 30-45
degrees with the tip of the pipette 130-150 um dorsal to the tip of the recording pipette.
Both pipettes were glued using a photo-polymerizing resin (Silux, 3M Dental Products,
St. Paul, MN). DAMGO intra-LC infusions were made by applying pulses of pressure to
the microinfusion pipette (15-25 psi, duration 10-30 ms) at a frequency of 0.2-1.0 Hz to
deliver a total microinfusion volume of 30 nl. Neuronal signals were amplified, filtered,
and monitored with an oscilloscope and a loudspeaker for localization of the LC. LC
neurons were tentatively identified by their spontaneous discharge rates (0.5-5.0 Hz). LC
single unit activity was recorded before, during, and after DAMGO microinfusion [0.1,
1.0, or 10.0 pg]. Only female rats were tested at [30.0 pg]. Only one dose of DAMGO
was tested on a single cell in an individual rat. The recording site was marked by
iontophoresis of PBS (-15 µA, 15 min) at the end of the experiment. Brains were
removed, and frozen 30 µm-thick coronal sections were cut on a cryostat before being
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mounted on gelatinized glass slides. The sections were stained with neutral red dye for
localization of the PSB spot.
Western Blotting. LC tissue punches were homogenized and centrifuged. Protein
content was determined using the BCA method. Protein extracts (10 µg) were subjected
to SDS-PAGE gel electrophoresis and then transferred to polyvinylidene fluoride
membranes (Immobilon-FL) as described (Curtis et al, 2006). Membranes were blocked
with Odyssey buffer (diluted in PBS 1:1) and incubated with specific primary antibody
overnight at 4o C to detect MOR (1:1000, rabbit anti-MOR, Invitrogen). Following
rinsing, membranes were incubated with infrared fluorescent secondary antibodies for
one hour (1:5000, donkey anti rabbit IRDye 800CW, LiCor, Lincoln, NE). Membranes
were scanned, and proteins were detected using the Odyssey Infrared Imaging System
(LiCor). Following quantification of the target protein (MOR), membranes were
incubated with the β-actin antibody (1:5000, mouse anti-β-actin, Sigma) for 90 minutes at
room temperature and a fluorescent secondary antibody with a different infrared
wavelength for one hour (1:5000 donkey anti-mouse IRDye 680CW, LiCor). Molecular
weights were determined using the Biorad Precision Plus Protein Standards.
Quantitative Polymerase Chain Reaction (PCR) Analysis of MOR mRNA.
LC tissue punches lyses and homogenizations. Samples were homogenized with mortar
and pestle in a Lysis buffer and a series of washing buffers (AMBION, Life
Technologies). DNA treatment was performed using the final RNA product plus DNAse
1 buffer and DNAse1 (AMBION, Life Technologies). Following RNA purification,
integrity of the samples was measured by spectrometry. All samples had A260/280 ratios
between 1.8-2.0. cDNA synthesis was performed using a High capacity cDNA reverse
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transcription kit (Applied Biosystems, Foster City, CA). The cDNA samples were then
diluted to a concentration of 20 ng/µl and stored for real-time PCR.
Real Time PCR. Each well consisted of a total volume of 20 µl reaction mixture
containing 10 µl of universal master mix, one µl of gene expression assay, 2 µl of cDNA
and 7 µl of RNAse-free H2O (QIAGEN, Germany). Each sample was loaded onto 96well plates and run in triplicates. Reactions were performed using an AB1 7500 Realtime PCR System (Applied Biosystems, Foster city CA) under the manufacturer’s
recommended settings.
Operant Chamber. Each box was equipped with a fan to provide air ventilation
and block out potentially distracting outside noises. Each chamber contained two levers
on either side of a food receptacle where grain-based food pellet rewards (45 mg;
BioServ, Frenchtown, NJ, USA) could be delivered. A stimulus light was positioned
above each lever, and a house light was positioned top-center on the wall opposite the
levers. Data was recorded and stored onto a PC computer via an interface module.
OSST Training. Rats were first trained to press one of two levers for food
reinforcement with one press resulting in food presentation. On the following day, rats
were trained to press the lever opposite to the one from the first day for food
reinforcement. On the third training day, rats were introduced to the trial structure of the
task, under conditions with no discernable rule. On each trial, the house light and both
stimulus lights were illuminated for 15 seconds during which rats could press one of the
two levers for food reward. One of the two levers was randomly selected to deliver
reward one, three, or five trials in a row, such that over many trials both levers were
equally likely to deliver a reward. This was done to encourage animals to press both
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levers during training while not allowing them to use spatial or light cues to reliably
predict which lever would deliver a reward. If the correct lever was pressed within 15
seconds of trial initiation, a single reward pellet was delivered and all lights remained
illuminated for 3 seconds followed by darkness for a 5-seconds timeout before initiation
of the next trial. If the incorrect lever was pressed within 15 seconds of trial initiation, no
reward was delivered and all lights were immediately shut off for a 10 second timeout
before initiation of the next trial. If neither lever was pressed within 15 seconds of trial
initiation, all lights were shut off for a 5-seconds timeout before initiation of the next
trial. Additionally, if either lever was pressed during a dark timeout period, the initiation
of the following trial would be reset to occur 5 seconds after the time of this lever press.
Trials continued until an animal achieved 50 correct trials. Each animal’s side bias was
determined to be toward the lever on the side that the animal pressed on the majority of
trials. The following day was the testing day.
MOR antibody specificity controls. The MOR antibody (1:1000, rabbit antiMOR, Invitrogen) used for protein quantification was tested for specificity using cortical
and heart tissue. The MOR protein is not expressed in the rat heart (Wittert et al, 1996)
whereas, it is abundantly expressed in cortex.
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Supplemental Figures and Legends

	
  

Figure 7. MOR antibody specificity control.
A Representative blot, A) Black and white, and B) Odyssey Infrared Imaging System
(LiCor) showing MOR protein (green) and GAPDH (red) immunoreactive bands (52 and
37 KDa, respectively) from cortical and heart tissue. The antibody against MOR detected
the protein in cortex but not in heart lysates. The same blots were probed to detect
GAPDH to confirm that the protein was loaded in the cortical and heart lanes. GAPDH
was detected in cortical and heart lysates of the same blot.
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Figure 8. Effect of intra-LC DAMGO on LC firing rate in male rats and female rats
at different estrogen statuses.
Bar graphs show the magnitude of the effect of DAMGO on LC discharge rate
represented as the area under the curve of the percent change from baseline after
DAMGO microinfusion into the LC. Males were administered 10 pg DAMGO (7 cells/5
rats). Because all but 2 female rats that were administered 10 pg DAMGO were
proestrus, the effects of the 10 pg and 30 pg doses were pooled. Red bars are the mean of
11 cells/6 rats in proestrus. Five of the cells were exposed to 10 pg and 6 were exposed to
30 pg. Blue bars are the mean of 6 cells/5 rats in diestrus/estrus. Two of these cells were
exposed to 10 pg and 4 were exposed to 30 pg. The mean AUC was greater in males
when compared to female groups at either high or low estrogen (One Way ANOVA: F (2,
23) =3.88 p=0.036, *p<0.05 compared to both female groups, Student’s t-test two tailed).
The inhibition produced by DAMGO in males was greater than that produced in females
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regardless of estrogen status and even though many of the female neurons were exposed
to a higher concentration of DAMGO.

	
  

Figure 9. LC-MOR mRNA levels in males and females at relatively different
estrogen levels.
Bars indicate relative quantification (RQ) of the MOR gene in the LC. Data are
represented as the mean (SEM). GAPDH was used as a loading control. Levels of
transcripts were comparable in females in an estrus cycle stage of high estrogen
(proestrus, 0.62+0.17, n=6), or relatively low estrogen (diestrus or estrus pooled,
0.72+0.17, p=0.71, n=8). For males, n=14.
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Figure 10. Effects of DAMGO on performance in the operant strategy set-shifting
task (OSST) in females at different estrogen levels.
Effects of ACSF and DAMGO (3 pg and 10 pg) bilaterally infused into the LC on
performance in the OSST in females. Female groups were broken down into relative
HIGH (proestrus) and LOW (diestrus/estrus pooled) estrogen levels. The bars indicate the
mean number of trials necessary to reach the criterion for side discrimination (SD), side
reversal (REV), and shift to light (SHIFT) stages of the task. Vertical lines represent
SEM. The number of rats for each group is shown in the graph legend.
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Figure 11. Location of 10 pg DAMGO infusions in and outside the LC.
The location of infusions was reconstructed onto figure 60 from Paxinos (1986). Black
filled circles represent infusions within the LC in males. Black filled squares represent
infusions outside of the LC in males. Red filled circles represent infusions within the LC
of females. Red filled squares represent infusions outside of the LC in females (Cb,
cerebellum; V, ventricle).
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CHAPTER 3: µ-OPIOID RECEPTOR ACTIVATION IN THE LOCUS
COERULEUS INCREASES SYNCHRONIZATION OF THE MALE, BUT NOT
FEMALE MEDIAL PREFRONTAL CORTEX
Abstract
Stress-related neuropsychiatric pathologies are more prevalent in females compared with
males. Activation of the locus coeruleus (LC)-norepinephrine (NE) system is a
component of the stress response that is thought to affect cognition. Evidence suggests
that endogenous opioid neuropeptides are released during stress to restrain LC activation,
and to facilitate a return to baseline activity when the stressor ends. Sex differences in
this opioid influence could be a basis for sex differences in stress vulnerability. We
previously demonstrated a decrease in µ-opioid receptor (MOR) mRNA and protein in
the LC of female compared to male rats. As a result, LC neurons of female rats were less
sensitive to inhibition by the µ-opioid receptor (MOR) agonist, DAMGO. Given that the
LC-NE system affects cognitive function through its projections to the medial prefrontal
cortex (mPFC), the present study determined whether LC-MOR activation translates to
changes in mPFC neural activity, and whether there are sex differences in this effect.
Local field potential (LFPs) were recorded from the mPFC of freely behaving male (n=4)
and female (n=4) rats before and following local LC microinjection of DAMGO (10 pg).
LFPs were analyzed as power spectral density plots and the power at different frequency
bands (delta 2-4 Hz, theta 4-8 Hz, alpha 8-12 Hz, and beta 12-20 Hz) was analyzed and
compared between sexes. Intra-LC DAMGO resulted in a time-dependent
synchronization of mPFC activity in male but not female rats. Specifically, DAMGO
increased synchronization in delta and alpha frequency bands. LC microinfusion of
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ACSF had no effect on mPFC activity in either male or female rats. Together, the results
are consistent with previous evidence for decreased MOR function in the LC of female
rats and demonstrate that this translated to a diminished effect on cortical activity.
Decreased LC-MOR function in females could contribute to greater stress-induced
activation of the LC, and increased vulnerability of females to hyperarousal symptoms of
stress-related neuropsychiatric pathologies.
Introduction
Stress-related neuropsychiatric pathologies are more prevalent in females relative
to males. For example, post-traumatic stress disorder (PTSD), and depression are nearly
two times more prevalent in females when compared with males (Kessler et al, 1994;
Kessler et al, 1995). These neuropsychiatric diseases are strongly associated with stress
and symptoms of hyperarousal (Wong et al, 2000). It is hypothesized that sex differences
in the prevalence of these stress-related neuropsychiatric diseases may be related to
differences in brain arousal systems and their regulation by stress. The major brain
norepinephrine (NE) nucleus, locus coeruleus (LC), is involved with arousal and
cognitive responses to stress and it is thought that the LC-NE system is dysregulated in
these stress-related psychiatric diseases. The LC is the principal site for NE synthesis in
the brain, and is the only source of NE in regions that are important in cognition such as
the cortex and hippocampus (Abercrombie et al, 1988b; Morrison et al, 1978;
Waterhouse et al, 1983). The LC neuronal discharge rate is positively correlated with
arousal state (Aston-Jones et al, 1981a; Berridge et al, 1991; Berridge et al, 1993) and
LC hyperactivity is thought to underlie the core feature of hyperarousal that characterizes
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stress-related neuropsychiatric diseases (Gold and Chrousos, 1999; Gold et al, 1996;
Koob, 1999; O'Donnell et al, 2004).
Electrophysiological studies have demonstrated that during acute stress, LC
neurons are co-regulated in an opposing manner by the stress-related neuropeptide
corticotropin releasing factor (CRF), which mediates excitation of LC neurons, and
endogenous opioids, which inhibit LC neurons, with CRF excitation predominating
(Curtis et al, 2001; Curtis et al, 2012). LC activation produced by CRF during stress has
been associated with increased arousal and cognitive flexibility (Snyder et al, 2012;
Valentino et al, 2008). On the other hand, endogenous opioids during stress, temper
CRF-mediated activation of the LC via the µ-opioid receptors (MOR) that are expressed
in LC neurons (Pert et al, 1976a), and promotes LC recovery when the stressor ends. Sex
differences could be expressed through differences in sensitivity to either CRF or to
endogenous opioids. Any sex differences in the opposing regulation of the LC-NE system
could be translated to differences in stress-sensitivity, and vulnerability to stress-related
psychiatric disorders. In a prior study, it was established that sex differences in CRF
signaling and trafficking in LC neurons of females (Bangasser et al, 2010) render females
into a dysregulated state of stress reactivity and could be linked to the development of
stress-related psychiatric disorders. In addition to this mechanism, decreased opioid
inhibition in the LC-NE system can contribute to vulnerability to stress-related illnesses.
We previously demonstrated that female rat LC neurons express less µ-opioid
receptor (MOR) mRNA and protein compared to males. Because of these molecular
changes in the LC, female rats are less sensitive to inhibition by the µ-opioid receptor
(MOR) agonist, DAMGO(Guajardo et al, 2017). Notably, the LC-NE system affects
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cognitive function through its projections to the medial prefrontal cortex (mPFC)
(Loughlin et al, 1986; Swanson et al, 1975), and stress-related dysfunctions in this
pathway are hypothesized to impair cognitive flexibility(Arnsten, 2009; Birnbaum et al,
1999). The molecular and cellular sex differences found in the LC were associated with
sexually distinct effects of LC-MOR activation on performance and cognitive processing
in an operant strategy-shifting task. On the basis of these observations, this study was
designed to determine how these molecular and cellular sex differences of the LC-MOR
system translates to changes in neural activity in PFC regions that guide cognitive
strategies.
Materials and Methods
Animals
Adult male (n=4) and female (n=4) Sprague Dawley rats (Charles River,
Wilmington, MA) were shipped from the vendor at ~70 days of age. Experiments were
conducted 1 week after arrival. Rats were singly housed in a climate controlled room
with a 12-h light–dark cycle (lights on at 0700 hours). Food and water were freely
available. Female rats were intact. Animal use and care was approved by the institutional
animal care and use committee of the Children’s Hospital of Philadelphia.
Surgery
Male and female rats were implanted with a single cannula guide into the LC (26
gauge, Plastics One, Roanoke, VA). Rats were anesthetized with isofluorane (2%) and
positioned in a stereotaxic instrument with the head tilted at a 15º angle to the horizontal
plane (nose down). A hole was drilled centered at LC coordinates relative to lambda: AP
-3.6 mm, ML ±1.1 mm, and the guide cannula was lowered to 5.0 mm below brain
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surface. The guide cannula was affixed to skull and skull screws with cranioplastic
cement. An obdurator was inserted into the guide cannula to prevent occlusion. During
the same surgery, a depth electrode (100 µm) (Microprobes for life science, Gaithersburg,
MD) was implanted in the mPFC (+3.2 AP, -0.6 ML, 3.0 DV) ipsilateral to the LCcannula guide for recording local field potentials (LFP). A ground wire was attached to
the skull and skull screws. Animals were allowed 5 days to recover before experimental
manipulations.
Drugs for intra-LC microinjections
Drugs used for intra-LC microinfusion were DAMGO ([D-Ala2, N-MePhe4, Glyol]-enkephalin; Abcam, Cambridge, MA), a synthetic opioid peptide with high MOR
specificity and clonidine HCl (Sigma, St Louis, MO). These compounds were aliquoted
and concentrated using a Speed Vac and stored at -20oC before experimental procedures.
On the day of the experiments, drugs were dissolved in artificial cerebrospinal fluid
(ACSF). The doses that were microinfused into the LC were DAMGO (10 pg in 200 nl)
and clonidine (50 ng in 200 nl). The dose of DAMGO is one that has been demonstrated
to produce sexually distinct effects on LC activity and on cognitive endpoints when
microinfused into the LC (Guajardo et al, 2017). The dose of clonidine has been
demonstrated to produce a long lasting cessation of LC spontaneous discharge without
altering baseline electroencephalograph (EEG) activity (Page et al, 1993).
Electrophysiological recordings
Experiments began at least 5 days after surgery. All mPFC recordings were
performed in the unanesthetized state. For each rat in the study, cables connected the
head-stage to a data acquisition system (AlphaLab; Alpha Omega; Nazareth Israel).

	
  

79	
  

Cannula (26 gauge, Plastics One, Roanoke, VA) were inserted into the guides and
secured using a connector that screws around the cannula guide when inserted. Tubing
connecting the cannula to the syringe pump was threaded through a flexible coil that
allowed free movement of the rat, yet maintained stability of the cannula in the guide. For
all animals in the study, pre-injection LFP recordings were taken for 60 minutes. This
allowed the rat to undergo multiple sleep/wake cycles that could be used to validate the
mPFC LFP recording. LFP activity was recorded and amplified at a gain of 5000 Hz,
bandwidth of 1-350 Hz. Following the pre-injection recording period, ACSF (200 nl),
DAMGO (10 pg in 200 nl), or clonidine (50 ng in 200 nl) was microinfused into the LC.
Recordings continued for 60 minutes after drug administration. ACSF and DAMGO were
administered to the same subjects on different days with treatments being 7 days apart.
Histology
After the experiment rats were anesthetized with isofluorane, pontamine sky blue
dye (PSB, 200 nl) was injected through the LC cannula to verify placement. Brains were
removed, and frozen 30 µm-thick coronal sections were cut on a cryostat and mounted on
pre-cleaned plus slides. The sections were stained with neutral red dye for localization of
the PSB spot (Figure 12A).
Data Analysis
LFP raw traces were time stamped in Spike2 to remove noise and converted to
Power Spectra Density (PSD) raw plots indicating the power in 128 bins from 0 to 20 Hz
using Neuroexplorer (Nex Technologies, Madison, AL). The power in different
frequency bands (delta, 2-4 Hz; theta, 4-8 Hz; alpha, 8-12 Hz; and beta, 12-20 Hz) was
calculated for each rat. A two-way repeated measures analysis of variance (rmANOVA)
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with sex as the between factor and time with respect to injection as the repeated measure
for each individual frequency band. The Tukey’s HSD was used for post hoc
comparisons between means. An alpha level of p<0.05 was the maximum threshold for
statistical significance. Post hoc tests were only performed if an interaction is indicated.
Results	
  

Effects of intra-LC DAMGO on cortical activity
DAMGO was microinfused into the LC of 4 male and 4 female rats. Figure 12
shows an example of histological verification of the injection site into the LC and the
location of injections in all rats. The local LC injection of DAMGO increased mPFC
synchronization in male rats. Representative raw LFP traces and their corresponding
spectrograms displaying power in different frequencies over time show an increase in
amplitude within 100 s after the injection that is consistently long lasting in the male rat.
In contrast, the LFP trace and spectrogram of the female rat suggests a less consistent and
shorter acting effect (Figure 13A and 13B). LFPs were analyzed as PSD plots and the
power in different frequency bands at different time blocks were analyzed and compared
between sexes (Figure 13C-13F). A two way repeated measures (rm) ANOVA indicated
an effect of Time (F (3, 4) =21.50, p<0.006), and a Sex X Time interaction for power in
the delta frequency band (F (3, 6) =28.4, p<0.003). There was a trend for effect of Sex (F
(1, 6) =5.34, p=0.06) and a trend for a Sex X Time interaction for power in the theta
frequency band (F (3, 4) =6.2, p=0.05). Analysis of power in the alpha frequency band
indicated an effect of Sex (F (1, 6) =11.20, p<0.01), and a Sex X Time interaction (F (3,
4) =6.93, p<0.04). There was no Sex X Time interaction for power in the beta frequency
band (F (3, 4) =4.75, p<0.08).

	
  

81	
  

Further analysis within specific frequency bands at different time blocks after
DAMGO administration (0 to 10 minutes, 10 to 15 minutes and 45 to 60 minutes)
revealed a time-dependent synchronization of mPFC activity such that there was no
significant effect of DAMGO in any frequency band at 0-10 minutes after injection
(Figure 13C and 1D). Notably, DAMGO significantly increased power in the delta and
alpha frequency bands at 10-15 minutes after administration in males only (delta, p<0.05;
alpha, p<0.05, Tukey’s HSD) (Figure 13C and 13D). At this time period, there was also a
trend for DAMGO to increase power in the theta frequency band selectively in male rats
(p=0.05). DAMGO effects recovered by 45-60 min post-injection (Figure 13E and 13F).
Lack of effect of intra-LC ACSF on mPFC network activity
In contrast to DAMGO, local ACSF injection into the LC did not affect mPFC
activity of the same rats (Figure 14). A two way ANOVA comparing power in different
frequency bands at different post-injection times revealed an effect of Sex (F (1, 6) = 7.5,
p=0.03), and no Sex X Time interaction for power in the delta (F (3, 4) =5.21, p=0.07).
No Sex X Time interaction for theta (F (3, 4) = 1.39, p=0.4), alpha (F (3, 4) = 2.61,
p=0.2) or beta (F (3, 4) = 3.30, p=0.14) frequency bands (Figure 14).
Comparable effects of intra-LC clonidine on cortical activity of male and female
rats
Like DAMGO, clonidine inhibits LC discharge rate, and intra-LC injection
increases cortical electroencephalographic synchrony of anesthetized rats (Berridge et al,
1993). Consistent with this, intra-LC microinfusion of clonidine (50 ng) increased the
LFP amplitude in rats not anesthetized. Notably, this effect appeared comparable in a
male and female rat (Figure 15A-15D).
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Discussion
The present results are consistent with previous findings of decreased MOR
function in the LC of female compared to male rats(Guajardo et al, 2017). Decreased
MOR mRNA expression and protein levels in the LC of female rats result in a decreased
efficacy of DAMGO to inhibit LC neuronal activity. This sex difference was particularly
apparent at doses (10 pg and 30 pg) that maximally inhibited male LC neurons. Notably,
these sex differences in LC-MOR function translated to a sexually distinct impairment of
performance of a prefrontal cortex-mediated cognitive task (Guajardo et al, 2017). The
current demonstration that LC-MOR activation by a similar DAMGO dose selectively
affects prefrontal cortical network activity of male rats links the previous molecular and
behavioral findings. Taken together, the results suggest that decreased MOR expression
in the LC of females relative to males, translates to an attenuation of the cortical response
to LC-MOR activation, and this can account for sexually distinct cognitive consequences
of LC-MOR activation. These sex-specific cognitive consequences are relevant for
understanding sex differences in opioid abuse. Additionally, given the evidence that
MOR activation in LC neurons may counteract stress effects on this system (Valentino et
al, 2008), the present findings suggest that sex differences in MOR expression contribute
to the increased vulnerability of females to the hyperarousal components of stress-related
disorders (Gold et al, 2002; Koob, 1999; Wong et al, 2000).
Relationship to previous studies
The LC regulates executive function and cognitive flexibility through its
widespread projections to the prefrontal cortex (Loughlin et al, 1986; Swanson et al,
1975). Previous studies demonstrated that selective pharmacological manipulations of LC
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neuronal activity are sufficient to affect cortical activity. For example, in anesthetized
rats, compounds that inhibited LC discharge rate such as the α2-agonist, clonidine, shifted
the power spectrum of cortical EEG towards a high-amplitude, low frequency state that
was similar to that seen during slow wave sleep (Aston-Jones et al, 1981a; Berridge et al,
1993). The effects of intra-LC DAMGO on cortical EEG activity recorded from screws
inserted into the frontoparietal and fronto occipital regions showed a similar effect
(Bagetta et al, 1990). Conversely, compounds that increased LC discharge rate such as
the cholinergic agonist bethanechol, induced cortical EEG desynchronization
characterized by low amplitude, high frequency activity (Berridge et al, 1991). Likewise,
intra-LC microinfusion of CRF increases LC discharge rate, and produces cortical EEG
desynchronization (Curtis et al, 1997). Notably, LC activation produced by CRF shifts
the mode of LC discharge towards a high tonic state that is thought to facilitate
behavioral flexibility (Curtis et al, 1997; Valentino et al, 1987, 1988a). Consistent with
this, relatively low doses of CRF injected into the LC improve cognitive flexibility in an
attentional set-shifting task mediated by the mPFC, and increase c-fos (an indicator of
neuronal activation) in mPFC neurons (Snyder et al, 2012). Taken together, these results
suggest that alterations in LC neuronal activity are sufficient to alter mPFC activity and
impact mPFC-mediated cognitive functions. Although MORs are highly expressed in LC
neurons, and engaging MOR in the LC impairs a mPFC-mediated cognitive task, its
effects on mPFC activity have not been documented previously. Importantly, decreased
MOR function in the LC of females relative to males resulted in sexually distinct
consequences in mPFC-mediated cognitive tasks, implying sex differences in the impact
of activating LC-MOR on mPFC neuronal activity. Therefore, in this study we quantified
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and compared the effects of activating LC-MOR on mPFC neuronal activity between
male and female rats.
Effects of LC-MOR activation on prefrontal cortex activity
Field potential measurements provide an excellent tool for the exploration of
network activity in mPFC. Previous studies of cortical network activity demonstrated that
inhibition of LC discharge by clonidine induced high-amplitude, low frequency cortical
oscillations (Berridge et al, 1993; de Sarro et al, 1988). Like clonidine, a DAMGO dose
that completely inhibited LC activity, increased high-amplitude, low frequency
oscillations in the mPFC. However, this effect was selective to male rats. The effects on
the mPFC network activity were not artifacts of injection, as these effects were not
reproduced with intra-LC infusion of ACSF. The effects of DAMGO on mPFC network
activity were also time-dependent in that they peaked at 10-15 min, and recovered by 4560 min. Although for females there was a trend for an immediate effect of DAMGO on
mPFC activity, this did not achieve statistical significance and was not apparent at later
times after the injection. The lack of effect of intra-LC DAMGO (10 pg) in females is
consistent with the reduced effect of the same dose on LC activity previously described,
and attributed to decreased MOR expression in the LC (Guajardo et al, 2017). Finally,
the observation that intra-LC clonidine produces comparable effects on mPFC activity in
males and females supports the notion that the sex differences in the DAMGO response
are due to differences at the level of MOR expression in the LC.
Sex Differences in Behavioral/Cognitive Endpoints of MOR Activation in the LC
Microinfusion of DAMGO into the LC produced sex-specific effects on a
strategy-shifting task thought to be mediated by the mPFC (Guajardo et al., 2017). For
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males, DAMGO significantly increased the time to complete the task, in part because it
increased premature responding. Overall, male rats administered DAMGO made more
errors during the task than females, particularly the number of regressive errors, which is
indicative of an inability to acquire and maintain the new strategy. Consequently, sexdifferences in LC-MOR expression that result in an enhanced ability of DAMGO to
regulate mPFC activity, translated to impairments in learning to shift strategies
selectively in males. Interestingly, female rats administered DAMGO into the LC
committed more perseverative errors than male rats, which is indicative of an impaired
ability to shift from a previously learned rule. Perseverative responding has been
attributed to brain regions other than the prelimbic region, which was the site of
recordings in the present study, including the infralimbic mPFC (Baran et al, 2010). This
may explain why DAMGO in the female LC can have behavioral effects in the absence
of electrophysiological effects in the prelimbic mPFC. A prior study using a place
recognition task demonstrated that female rats were more sensitive to disruption of the
infralimbic cortex as indicated by increased perseverative responding (Baran et al, 2010).
Taken with the present results, this suggests that DAMGO in the LC of females may
sufficiently affect activity in cortical regions, other than the prelimbic mPFC, that
regulate other cognitive processes. In this way engaging MOR receptors in the LC can
have sexually distinct effects on cognitive processing.
mPFC activity and strategy-shifting are physiological and behavioral endpoints of
LC-MOR activation, respectively. Because for both endpoints, the same intra-LC dose of
DAMGO was tested and the experimental time-courses were comparable, the temporal
relationship between cortical activity and behavior can be assessed. The time during
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which DAMGO had a maximal effect on cortical activity in male rats (10-15 min post
injection) corresponded to performance of the simple discrimination stage of the task.
DAMGO (10 pg) tended to enhance side discrimination performance when compared to
vehicle control in males only, suggesting that mPFC synchronization may protect against
distraction and is optimal for learning simple tasks.
At the time point corresponding to strategy-shifting stage of the task (45 min),
mPFC network activity in males partially recovered while effects on behavioral
performance were apparent. This suggests an enduring effect on mPFC neuronal function
that may not be expressed as changes in network activity. Alternatively, the discrepancy
in the temporal correlation between physiological and behavioral endpoints may be a
function of not recording both simultaneously in the same subject.
Conclusion
Taken with our previous findings, the current findings demonstrate that the
consequences of activating LC-MOR on mPFC activity and function are greatly
diminished in females as a result of decreased MOR expression. MOR in the LC serves to
counter stress-elicited excitation that is mediated by CRF and promotes recovery. The
impact of reduced LC-MOR influence during stress coupled with increased CRF receptor
signaling in females (Bangasser et al, 2010) would be predicted to result in a prolonged
hyperactivity of the LC-NE system in response to stress and hyperarousal symptoms that
characterize stress-related disorders in females(Gold et al, 2002; Koob, 1999; Wong et al,
2000).
Sex differences in LC-MOR function also have implications for sex differences in
opioid abuse. In male rats, repeated social stress causes an imbalance between
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endogenous opioids, and CRF which favors opioid regulation (Chaijale et al, 2013). The
increased opioid influence in the LC would be predicted to promote premature
responding, which is indicative of impulsive behavior (Pattij et al, 2009) in males only
(Guajardo et al, 2017). Impulsivity is a key feature associated with opioid abuse
(Baldacchino et al, 2015).These cellular alterations in LC after chronic stressors, coupled
with the cognitive consequences of LC-MOR activation may predispose males to opiate
abuse.The present study underscores how sex differences at the molecular level can
translate to sex differences in network activities that govern behavior and cognition.
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Figures and Legends

Figure 12. Histological verification of intra-LC injection and mPFC electrode
placement.
Brightfield photomicrograph of a neutral red counterstained section through the LC
showing histological verification of the single injection site. (A) Arrow points to the LC
and the arrowhead points to the dye, which is localized to the LC (Cb, cerebellum; V
ventricle). (B) Neutral red counterstained section through the prelimbic mPFC (PrL)
showing histological verification of the recording electrode placement. Arrow points to
the electrode track (IL, infralimbic mPFC).
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Figure 13. Intra-LC DAMGO resulted in a time-dependent synchronization of
mPFC activity in male but not female rats.
Representative time-frequency spectrograms of mPFC LFP activity generated from a
male and female rat. (A and B) Power in different frequencies (ordinate) is indicated as
color (hotter colors being greater). DAMGO (10 pg in 200 nl) was microinfused into the
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LC at white vertical line. (C and D) The bar graphs represent the mean raw power
spectral density values at different frequency bands (delta 2-4 Hz, theta 4-8 Hz, alpha 812 Hz and beta 12-20 Hz) in male (n=4) and female (n=4) rats, respectively, determined
10 min before (pre-injection), 0-10 min, 10-15 min, and 45-60 min after intra-LC
DAMGO on mPFC network activity. Error bars represent ± SEM. *p<0.05. (E and F)
The line graphs are power spectral density (PSD) plots indicating the raw power of the
mPFC LFP at different frequencies. These line graphs were generated from the same
subjects as shown in A and B, 10 min before (pre-injection), 0-10 min, 10-15 min, and
45-60 min after intra-LC DAMGO on mPFC network activity in males and females.
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Figure 14. Lack of effect of intra-LC ACSF on mPFC network activity.
Bar graphs represent the mean raw power in different frequency bands at different times
before and after intra-LC ACSF (200 nl) in the same male and female rats indicated in
Figure 13 above. A) Males and B) Females at different time blocks (0-10, 10-15, 45-60
minutes after Intra-LC DAMGO injection). Error bars represent ± SEM.
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Figure 15. Similar effects of intra-LC clonidine on mPFC network activity.
Time-frequency spectrograms of mPFC LFP activity from a male and female rat before
and after (A and B) clonidine (50 ng in 200 nl). Power in different frequencies (ordinate)
is indicated as color. The vertical white line indicates the time of microinfusion. (C and
D) Power spectral density plots corresponding to their respective time-frequency
spectrograms shown above.
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CHAPTER 4: GENERAL CONCLUSIONS AND FUTURE DIRECTIONS
Sex differences are increasingly recognized as important in the prevalence and
severity of neurological and psychiatric diseases. This dissertation explored the role of
sex in a major stress response system in the brain, the Locus Coeruleus (LC)Norepinephrine (NE) system, as a factor of stress vulnerability. By implementing
electrophysiological, biochemical, and behavioral approaches, sex differences in µ-opiate
receptor (MOR) function in the LC that could underlie stress vulnerability were
examined. In the first set of experiments in Chapter 2, it was determined that female rat
LC neurons express less MOR mRNA and protein compared to males. Because of these
molecular differences, female rat LC neurons are less sensitive to inhibition by the
selective MOR agonist, DAMGO. Notably, the LC-NE system affects cognitive function
through its projections to the medial prefrontal cortex (mPFC) (Loughlin et al, 1986;
Swanson et al, 1975), and stress-related dysfunctions in this pathway are hypothesized to
impair cognitive flexibility (Arnsten, 2009; Birnbaum et al, 1999). The molecular and
cellular sex differences found in the LC were associated with sexually distinct effects of
LC-MOR activation on performance and cognitive processing in an operant strategyshifting task. In Chapter 3, the molecular and cellular sex differences in LC-MOR were
further investigated through the activation of LC-MOR on PFC network activity that
guides cognitive strategies. The decreased efficacy of DAMGO on LC activity translated
to a diminished effect on mPFC network activity in females, and was consistent with less
disruption of an mPFC-mediated operant task in females. Taken together, the results
suggest that decreased MOR expression in the female rat LC is sufficient to result in a
decreased ability to inhibit LC neurons and to affect PFC network activity, and this

	
  

104	
  

translates to sexually distinct cognitive effects. Sexually distinct cognitive effects of
MOR activation in the LC may play a role in sex differences in vulnerability to aspects of
opioid abuse. Additionally, given the role of opioids in tempering LC activation during
stress, sex differences in opioid inhibition of LC neurons could contribute to female
vulnerability to stress-related psychiatric disorders.
Sex Differences in MOR Expression
The MOR is highly expressed in the brain, and has been demonstrated in studies
showing high correspondence between the MOR mRNA and receptor binding
distributions in many brain regions including the LC (Mansour et al, 1994; Mansour et al,
1987). MORs are highly expressed by LC neurons, and MOR agonists potently inhibit
LC neuronal activity (Mansour et al, 1994; Williams et al, 1984). Notably, sex
differences in MOR expression have been documented in the brain. For example, in the
anterior pituitary gland, MOR expression in female rats is decreased relative to males
(Carretero et al, 2004). In addition, female rats express significantly less MOR in the
periaqueductal gray relative to males (Loyd et al, 2008). Notably, Estrogen status in
females appears to play a role in the modulation of MOR expression in the periaqueductal
gray. Consistent with these findings, in Chapter 2 it was determined that females
expressed less MOR in the LC compared with males. Western blot analysis revealed
decreased MOR protein in female LC relative to male LC. This result was corroborated
with mRNA studies indicating decreased MOR mRNA transcripts in female LC when
compared with male LC. Importantly, sex differences in MOR expression in the LC were
independent of female estrogen status as determined by measuring mRNA transcript
levels in the LC of females at different stages of the estrous cycle. This suggests that sex
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differences arise from the organizational effects of female hormones early in
development.
Sex Differences in MOR Activation on Neuronal Activity
MORs are highly distributed within the LC (Mansour et al, 1994; Williams et al,
1984). The MOR is prominently localized postsynaptically within noradrenergic somato
dendritic processes (Van Bockstaele et al, 1996a; Van Bockstaele et al, 1996b). Potent
inhibitory effects of MOR activation on LC neurons have been well documented. MOR
activation inhibits the formation of cyclic AMP and hyperpolarizes LC neurons through
an increase in potassium conductance (Aghajanian et al, 1987; Williams et al, 1984).
The electrophysiological studies conducted in Chapter 2 were the first to examine
and compare sex differences in LC postsynaptic responses to MOR agonists. Although
there are reports of sex differences in opioid-induced analgesia and behavioral
suppression elicited by opioids (Craft, 2003; Kest et al, 2000a), there are no reports on
sex differences characterizing the electrophysiological effects of activation of MOR in
the brain. Few studies have investigated functional sex differences in other receptors in
the LC. One study found that female LC neurons are more sensitive to exogenous CRF
relative to males, and this was attributed to differences in CRF receptor coupling to the
GTP-binding protein, Gs (Bangasser et al, 2010; Curtis et al, 2006).
In contrast to the aforementioned sex difference in CRF receptor sensitivity, the
present study identified sex differences in the maximal effect of MOR activation. Based
on the electrophysiological assessment of MORs in the LC indicated in Chapter 2, the
maximum magnitude of inhibition produced by the MOR agonist was significantly less in
females, even when the dose was increased beyond that which completely inhibited male

	
  

106	
  

LC (10 pg). Thus, sex differences in LC MOR expression are sufficient to result in a
decreased efficacy of MOR agonists in inhibiting LC neuronal activity.
LC Regulation of Cortical Activity
If the sex differences in MOR expression in the LC that were observed in Chapter
2 are relevant, they should be reflected as sex differences in LC modulation of its
postsynaptic neuronal targets. The LC has widespread projections to the prefrontal
cortex, and through its modulation of cortical neuronal activity it can regulate executive
function and cognitive flexibility (Loughlin et al, 1986; Robbins and Arnsten, 2009;
Swanson et al, 1975). Therefore, sex differences in LC-MOR expression and in the
ability of intra-LC DAMGO to inhibit LC neurons should be expressed as differences in
LC modulation of cortical activity and its behavioral consequences.
Previous studies have demonstrated that selective pharmacological manipulations
of LC neuronal activity are sufficient to affect cortical activity. For example, in
anesthetized rats, compounds that inhibited LC discharge rate such as the α2-agonist,
clonidine, shifted the power spectrum of cortical EEG towards a high-amplitude, low
frequency state that was similar to that seen during slow wave sleep (Aston-Jones et al,
1981a; Berridge et al, 1993). The effects of intra-LC DAMGO on cortical EEG activity
recorded from screws inserted into the frontoparietal and fronto occipital regions showed
a similar effect (Bagetta et al, 1990). Conversely, compounds that increased LC
discharge rate such as the cholinergic agonist bethanechol, induced cortical EEG
desynchronization even in anesthetized rats (Berridge et al, 1991). Likewise, intra-LC
microinfusion of CRF increases LC discharge rate and produces cortical EEG
desynchronization (Curtis et al, 1997). Together, these studies provided strong evidence
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that regionally selective manipulation of LC discharge is sufficient to alter cortical
activity. LC activity is also necessary for cortical activation by stressors. For example,
cortical activation by hypotensive stress is prevented by selectively silencing the LC with
the α2-agonist, clonidine (Page et al, 1993).
The experiments conducted in Chapter 3 examined how molecular and cellular
sex differences of the LC-MOR system found in Chapter 2, affected LC modulation of
mPFC network activity that guides cognitive strategies. To our knowledge, these studies
were the first to systematically quantify the impact of the effects of MOR activation in
the LC on mPFC activity in both male and female rodents. A novel sex difference was
found in the effects of the MOR agonist, DAMGO, in the LC on cortical network
activity. Notably, administration of DAMGO at a dose that completely inhibits LC
activity increased cortical synchronization of in males only. The effects of intra-LC
DAMGO on mPFC network in males were time-dependent. Although there was a trend
for an immediate effect of DAMGO on mPFC activity in females, this did not achieve
statistical significance, and was not apparent at later times after treatment. These results
are consistent with a previous study demonstrating that intra-LC DAMGO increases
cortical synchrony of male unanesthetized rats (Bagetta et al, 1990). However, the
present studies were a refinement in demonstrating that much lower doses (10 pg in the
current study vs. 15 ng in the previous study) increase the LFP amplitude, specifically in
the mPFC. Most importantly, it was demonstrated that this effect is sex specific. As the
LFP recorded in the mPFC is modulated by LC-MOR activation, the results confirmed
the sex difference in LC-MOR expression, and the functional activity revealed in Chapter
2.
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LC Regulation of Cognitive Function
A quantifiable endpoint of mPFC function is cognitive flexibility. The LC
regulates cognitive flexibility through its projections to the mPFC (Loughlin et al, 1986;
Swanson et al, 1975). Lesions of LC-cortical projections impair cognitive flexibility (Tait
et al, 2007). The relationship between LC activity and PFC function is hypothesized to
resemble an inverted U-shaped curve, whereby PFC function is optimal at moderate
levels of LC activity. However, just as removal of LC-NE drive impairs cognitive
flexibility, so can excessive LC drive as a result of the interaction of higher levels of
norepinephrine with lower-affinity adrenergic receptors, including α1- and β-adrenergic
receptors (Arnsten, 2011). CRF, microinfused into the LC at doses that produce a
moderate activation of LC neurons, facilitates cognitive flexibility in an attentional setshifting task. However, this effect reverses as the CRF dose is increased (Snyder et al,
2012).
Sex differences in the effects of LC-MOR activation on mPFC network activity
should translate to sex differences in endpoints of cognitive flexibility. The behavioral
studies in Chapter 2 were unique in testing the impact of intra-LC administration of a
MOR agonist on the performance of mPFC-mediated cognitive tasks in both male and
female rats. Two important discoveries arose from this experiment. First, males were
more impaired in strategy shifting after activation of LC-MOR, as indicated by an
increased number of errors. This is in line with the enhanced effect of intra-LC DAMGO
on mPFC network activity in males. An unexpected finding was that there were sex
differences in the error type. Although females made fewer errors than males when LCMORs were engaged, the types of error were different. One explanation for this is that
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activating MOR in the LC affects different targets in male and female rats, with a bias
towards impairment in the prelimbic mPFC in males, and perhaps the infralimbic PFC or
orbitofrontal cortex in the female. LFP recordings in these latter LC targets during intraLC DAMGO infusion could test this hypothesis.
Sex Differences in Opioid Regulation of the LC-NE System and its Implications for
Vulnerability to Stress-Related Psychiatric Disorders
Stress-related neuropsychiatric pathologies are more prevalent in females relative
to males. For example, post-traumatic stress disorder (PTSD) and depression are nearly
two times more prevalent in females compared with males (Kessler et al, 1994; Kessler et
al, 1995). Given that PTSD and depression are strongly associated with stress, and stress
is thought to exacerbate neurological and psychiatric diseases, it has been hypothesized
that higher rates of psychiatric diseases in females are due to sex differences in stress
reactivity. Notably, a vast number of neuropsychiatric conditions such as depression and
post-traumatic stress disorder (PTSD) are strongly associated with dysfunctional stress
responses and symptoms of hyperarousal (Gold et al, 2002; Heim et al, 2001; Wong et al,
2000). Given its role in arousal, sex differences in the LC-NE system could underlie
female vulnerability to neuropsychiatric disorders that are characterized by hyperarousal
(Aston-Jones et al, 2005; Berridge et al, 2003). During acute stress, LC neurons are
activated by CRF, and this is associated with enhanced arousal and cognitive flexibility
(Snyder et al, 2012; Valentino et al, 2008). CRF mediates stress-induced LC activation,
and sex differences in CRF signaling and trafficking in LC neurons have been reported.
For example, CRF1-Gs association is greater in females compared to males, and stressinduced CRF1 association with β-arrestin 2, a step that is critical for CRF1 internalization
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is decreased in female relative to male rats. Consistent with this, stress induces CRF1
internalization in LC neurons of male rats, but not female rats (Bangasser et al, 2010).
Sex differences in CRF signaling have been proposed as one mechanism underlying LCNE dysregulation that contributes to female vulnerability to stress-related psychiatric
disorders.
In addition to CRF release in the LC, endogenous opioids are released, and these
serve to temper stress-elicited excitation that is mediated by CRF and promote recovery
of LC neurons (Curtis et al, 2012). The findings in this dissertation suggest that the
ability of endogenous opioids to temper LC activation during stress, and to promote LC
neuron recovery would be less effective in females. The impact of reduced LC-MOR
influence during stress coupled with increased CRF receptor signaling in females
(Bangasser et al, 2010) would be predicted to result in a prolonged hyperactivity of the
LC-NE system in response to stress and hyperarousal symptoms that characterize stressrelated disorders in females (Gold et al, 2002; Koob, 1999; Wong et al, 2000).
Sex Differences in Opioid Regulation, Cognitive Processing and Vulnerability to
Opiate Abuse
In drug abuse, opioids produce their reinforcing effects by increasing the activity
of the mesolimbic dopaminergic (DA) system (Di Chiara and Imperato, 1988; Koob and
Bloom, 1988; Wise and Rompre, 1989), which projects to extensive areas of the PFC
(Thierry et al, 1973). Chronic abuse of opioids alters opioid receptor functions in the PFC
(Mansour et al, 1988) and produces adaptive alterations in the cellular and synaptic
function of DA system (Nestler, 2001). Sex differences are present in all of the phases of
drug abuse, for example in the initiation, escalation of use, addiction, and relapse. In
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general, males have higher rates of use or dependence relative to females (Brady and
Randall, 1999). However, females may be more susceptible to craving (Fox et al, 2014;
Hitschfeld et al, 2015; Kennedy et al, 2013; Robbins et al, 1999) and relapse (Kippin et
al, 2005; Rubonis et al, 1994). Sex differences in LC-MOR function may have
implications for sex differences in opioid abuse. The sex-specific effects of LC-MOR
activation on cognitive processing may be relevant for understanding sex differences in
opioid abuse and for sex-specific design of treatment for opioid addiction.
The activation of the LC-MOR promoted premature responding in males only, a
response that is indicative of impulsive behavior (Dalley et al, 2011; Pattij et al, 2009).
Impulsive behavior, for which a simple definition is the tendency to act prematurely
without foresight, is associated with most forms of drug taking. It is often considered to
be a product of impaired cognitive control, and could potentially affect several aspects of
the addictive process. Notably, impulsivity is a key feature associated with opioid abuse
(Baldacchino et al, 2015). Previous studies have shown that opioids elicit impulsive
behavior in rodents in behavioral tasks such as the 5-choice serial response time task (5CSRTT) and the response inhibition task, and a decrease in motor impulsivity in MORknockout mice (Mahoney et al, 2013; Olmstead et al, 2009; Pattij et al, 2009).
Evidence in the literature suggests that PFC hypoactivity results in deficit of
functions such as inhibitory control, attention, planning, and risk-taking (Aron et al,
2004; Gazzaley and Nobre, 2012; Nee and Jonides, 2008), and lead to greater cognitive
and motor impulsivity (Dalley et al, 2011). Notably, lesions to the PFC produce profiles
of impulsivity (Brennan and Arnsten, 2008). Our electrophysiological studies revealed
that when MORs in the LC are engaged after agonist treatment, upstream targets such as
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PFC activity is disrupted. Decreased PFC function produced by the engagement of MOR
in the LC of males may account for the greater promotion of impulsive behavior during
the cognitive task. This sex specific-cognitive consequence produced by the LC-MOR,
when activated, may facilitate opioid taking and perhaps contribute to the higher rates of
opiate abuse in males.
Interestingly, in male rats, repeated social stress causes an imbalance between
endogenous opioids, and CRF that favors opioid regulation (Chaijale et al, 2013). After a
single social stress exposure, CRF and enkephalin afferents to the LC are engaged;
however, LC activation is predominant (Reyes et al, 2015). After repeated social stress,
CRF receptors become downregulated and MOR becomes upregulated, particularly in
rats with an active coping strategy. The increased opioid influence in the LC would be
predicted to promote impulsive behavior. These cellular alterations in LC after chronic
stressors, coupled with the cognitive consequences of LC-MOR activation, may
predispose males to opiate abuse. Our recent studies in females indicate that acute social
stress has similar effects as in males. However, with repeated social stress, MOR
becomes downregulated in the female LC, thus this compensatory mechanism may be
impaired. This would make females more vulnerable to hyperarousal symptoms of stress.
Studies show that females are more vulnerable to some phases of drug abuse such
as drug craving and relapse (Fox et al, 2014; Hitschfeld et al, 2015; Kennedy et al, 2013;
Kippin et al, 2005; Robbins et al, 1999; Rubonis et al, 1994) relative to males. Previous
studies suggest that once initiated, substance abuse accelerates at a faster pace in females
compared with males, craving is more severe, and it is more difficult to quit (Back et al,
2011; Becker et al, 2008). Notably, the engagement of LC-MOR selectively produced
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perseverative behavior in females in the cognitive task. Studies in rats have shown that
inhibition of the thalamo-cortical circuitry selectively increases perseverative behaviors
(Block et al, 2007). Additionally, disruption of the orbitofrontal cortex produces
perseveration and resistance to extinction of reward-associated behaviors in laboratory
animals (Butter et al, 1963; Johnson and Rosvold, 1971).
Consistent with animal studies, human studies suggest that disruption of the
thalamo-orbitofrontal circuit results in the perseverative behavior in addicted subjects,
and the exaggerated motivation to procure and administer the drug regardless of its
adverse consequences. This idea is supported by imaging studies showing disruption of
the thalamic and orbitofrontal brain regions in drug abusers (Volkow et al, 1996). The
thalamic and orbitofrontal regions are direct upstream targets of the LC-NE system
(Chandler et al, 2014; Samuels et al, 2008). The sex specific-consequence of LC-MOR
activation may lead to dysfunction of the thalamic-orbitofrontal circuit, resulting in
perseverative behavior that may predispose females to opioid craving and relapse. These
findings underscore the potential for sex-specific treatments of opioid abuse based on
pharmacological and/or cognitive therapies that target different cognitive dimensions.
Future Directions
The results described in this dissertation were interpreted on the basis of
reasonable assumptions and some of these results could be validated by further
experimentation. Several follow-up experiments could be performed to further support or
extend the conclusions drawn from this dissertation. For example, sex differences in the
response to DAMGO in the LC could result in part from MOR signaling. Examining and
comparing MOR coupling to its GTP-binding protein, Gi, using the GTPγS method in
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both sexes, could test this. This technique measures the level of G protein activation
following DAMGO occupation of MOR in the LC. The [35S] GTPγS binding assay
replaces endogenous GTP, and binds to the G-α subunit following activation of the
receptor to form a Gα-[35S] GTPγS species. Since the γ-thiophosphate bond is resistant to
hydrolysis by the GTPase of Gα, G-protein is prevented from reforming as a heterotrimer
and thus [35S] GTPγS labeled Gα-subunits accumulate, and can be measured by counting
the amount of [35S]-label incorporated (Harrison and Traynor, 2003).
To determine whether there are sex differences in intracellular signaling pathways
initiated by MOR, Designer receptors exclusively activated by designer drugs
(DREADD) technology could be used. The MOR is linked to Gi and selective
engagement of Gi-signaling in the LC can be accomplished using DREADDs. LC
neurons can be transduced to express DREADDs coupled to Gi. Administration of the
DREADD ligand, clozapine-N-oxide (CNO), would bypass MOR to then engage Gi
signaling. A follow-up study would be to record local field potentials in mPFC in animals
expressing the inhibitory Gi-coupled DREADDs in the LC while CNO is administered.
This follow-up experiment would provide a direct comparison of the mPFC network
activity while LC-NE neurons are inhibited via Gi-coupled DREADDs, with the mPFC
network activity results obtained in Chapter 3, when LC neurons were inhibited with
DAMGO in both sexes. Sex differences in the DREADD response to CNO would suggest
that there is a general sex difference in the Gi-intracellular signaling pathway, on the
other hand, no differences between the sexes in the DREADD response to CNO would
suggest that the difference is at the level of the MOR exclusively.
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Other experiments could be performed to answer questions that arose from the
results of this dissertation. For example, in Chapter 3, the discrepancy in the temporal
correlation between physiological and behavioral endpoints of LC-MOR activation arise
from not recording mPFC network activity during the performance of the mPFCmediated cognitive task simultaneously in the same subject. Recording mPFC network
activity during the performance of the mPFC-mediated cognitive task could assess this
correlation. This study would provide a real-time picture of circuit dynamics of the mPFC
network activity during task performance between the sexes.
Additionally, further experiments can be conducted in order to characterize the
effects of intra-LC DAMGO on LC neuronal activity and mPFC network activity during
the OSST performance. Recording LC unit activity and LC-LFPs after intra-LC DAMGO
administration while the animals are performing the cognitive task, and at the same time
recording mPFC-LFPs, would dissect the specific role of the LC-NE system on the sexspecific cognitive consequences produced in the cognitive task. Previous
electrophysiological studies suggest that application of opiates in the LC inhibits tonic
LC-neuronal discharge (Valentino et al, 1988c). Based on this observation coupled with
the results in the anesthetized LC-single unit study, we predict that intra-LC DAMGO at
relative high doses would produce an enhanced inhibitory effect in males relative to
females on tonic LC-neuronal discharge rate. This study would provide a characterization
of LC unit activity under the influence of DAMGO that underlies correct trials, premature
responses, and different error types.
Furthermore, by recording mPFC network activity in the same animal, coherence
analysis between the LC and mPFC can be achieved. Coherence analysis would reveal
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the strength of communication between these two brain regions during task performance.
We predict that LC-mPFC network communication will be decreased in male and female
animals treated with DAMGO during the strategy-shifting (SHIFT) component.
However, we expect that male coherence would be greatly disrupted, relative to females,
during the SHIFT component of the task, and that coherence will be increased in males
during the simple discrimination task. Our predictions on coherence are based on the
behavioral results during the performance of males at the simple discrimination stage, in
which DAMGO, at a high dose, improves performance relative to control and greatly
impaired performance during the SHIFT component of the OSST.
Moreover, this study would reveal the strength in LC-mPFC communication
during correct trials, premature responses, and different error types. Although, this
experimental procedure appears technically challenging, considering the size of the LC, it
would require a microwire bundle and a cannula being implanted chronically in the LC
and an electrode in mPFC. The best way to achieve this experimental procedure would be
using inhibitory Gi-coupled DREADDs to selectively manipulate LC neuronal activity;
however, as discussed earlier in this section, it must first be determined whether the Gicoupled DREADDs in the LC turns on the same intracellular pathways activated by
MOR in the LC.
A set of experiments can be conducted in order to assess the impact of sex
differences in cognitive processing in opioid taking and relapse. The premature
responding produced by the engagement of the LC-MOR in males indicates impulsive
behavior. Impulsivity is a key feature associated with opioid abuse (Baldacchino et al,
2015). Previous studies suggest that PFC disruption elicits impulsive behaviors (Brennan
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et al, 2008; Dalley et al, 2011). Consistent with this, the highest dose of intra-LC
DAMGO in our studies produced PFC network activity disruption and impulsivity in the
cognitive task. Based on these results, we hypothesize that impulsivity elicited by the
engagement of LC-MOR in males would facilitate opioid taking. Administering intra-LC
DAMGO or vehicle control in both sexes, and implementing an operant conditioning
paradigm underlying acquisition/initiation of opiate drugs could test this hypothesis. We
expect that males, after DAMGO treatment, will be more vulnerable than females to
acquisition/initiation of opioids under the conditions of this experimental procedure. On
the other hand, intra-LC DAMGO produced perseveration in females.
It is hypothesized that disruption of the thalamo-orbitofrontal cortex (OFC) circuit
underlies perseverative behavior in drug abusers (Volkow et al, 1996). Although, none of
our studies tested the effects of intra-LC DAMGO in thalamus and OFC, both brain areas
are upstream targets of LC (Chandler et al, 2014; Samuels et al, 2008). A set of
experiments can be performed in order to test the effects of the engagement of MOR in
the LC on these areas that govern perseveration and on relapse. A first set of experiments
would be testing the effects of intra-LC DAMGO on thalamic and OFC neuronal activity.
Based on the results of the cognitive task in which intra-LC DAMGO produced
perseverative behavior, we hypothesize that the engagement of LC-MOR disrupts
neuronal activity in thalamus and OFC in females only. To test this idea, thalamic and
OFC network activity can be recorded while DAMGO is microinfused into the LC.
Moreover, recording thalamic and OFC network activity during OSST task engagement
in animals treated with DAMGO in the LC would provide a real-time picture of circuit
dynamics in these brain regions underlying perseverative behavior.
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Second would be assessing how sex differences in perseveration produced by the
engagement of LC-MOR impacts relapse in opiate addiction. We hypothesize that the
sex-specific effects of intra-LC DAMGO on cognitive processing in females that
produced perseveration will render females more vulnerable to relapse. In order to test
this hypothesis, reinstatement procedures used to model relapse following a period of
abstinence can be implemented. Reinstatement procedures require previous exposure to
opioids that may alter LC-MOR function; therefore, blocking LC-MOR antagonists
would be appropriate to test this question. After a period of abstinence, application of the
selective MOR antagonist CTAP can be microinfused into the LC in both sexes, and
reinstatement can be tested. CTAP is a potent MOR antagonist (Chieng et al 1996). We
hypothesize that blockage of LC-MOR by CTAP will prevent reinstatement in females.
Our studies focused on the effects of the local activation of MOR in the LC and
its consequences on electrophysiological and cognitive endpoints. In general, the main
route of administration of drugs of abuse is systemically. Conducting experiments
evaluating sex differences in response to systemically delivered opioids on cortical
activity and behavior relevant to opioid abuse would expand the findings presented in this
dissertation. Notably, systemic administration of opioid agonists produces mPFC
hypofunction.
Previous studies in rats suggest that systemic and local administration of opioid
agonists decrease excitatory neurotransmission in mPFC. Specifically, systemic
administration of opioid agonists diminishes cellular response to excitatory activation of
three major mPFC afferents such as thalamus, basolateral amygdala, and hippocampus
(Giacchino and Henriksen, 1998). Consistent with these findings, our studies suggest that
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in males, local administration of opioid agonists in the LC decreases mPFC function.
Further experiments can be conducted in order to dissect the specific role of the LC-MOR
system in the modulation of PFC function when opioid drugs are systemically delivered
to the brain, and whether sex differences in cognitive processing produced by a local
administration of opioid agonists in the LC are produced by systemic administration of
opioids.
To examine the specific role of the LC-MOR system on PFC modulation during
systemic administration of opioids, mPFC network activity can be recorded while the
animals receive a dose of systemic opioids at the same time as application of the selective
MOR antagonist CTAP intra-LC. CTAP is a potent MOR antagonist (Chieng et al, 1996).
Blockage of MORs in the LC will remove the LC-MOR influence to mPFC when opioid
agonists are delivered systemically and take effect on the brain. Previous studies in male
rodents show that systemic morphine administration induced cortical EEG slow wave
synchronization in naive animals (Lukas et al, 1982).
Our electrophysiological studies showed a similar effect when DAMGO was
microinfused intra-LC in males only. Based on this observations, we hypothesize that
blockage of LC-MOR will translate to decreased cortical network activity
synchronization at lower frequency bands, when systemically delivered opioid agonists
take effect on mPFC network activity of males. We also hypothesize that cortical network
activity in females will be unaffected by systemic delivered opioid agonists, a similar
effect produced by intra-LC DAMGO.
A major finding in this dissertation is that intra-LC DAMGO at a high dose
produced sex differences in cognitive procession during the SHIFT stage of the cognitive
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task. It would be pertinent to further investigate the cognitive processing produced by the
engagement of LC-MOR through the local administration of DAMGO in the LC, and
evaluate if systemic administration of opioid agonists produce sex differences in
cognitive processing during performance of the OSST. To answer this question, animals
would be tested on the different components of the OSST under the effects of
systemically delivered opioid agonists. One possible outcome is that the systemic
injection of opioid agonists may produce the same sex-specific cognitive consequences
produced by intra-LC DAMGO. In that case, it would be important to corroborate if these
sex-specific behaviors are produced by the MORs engagement in LC projections to PFC
or other brain structures. One way to achieve this is by antagonizing MORs in LC while
the animals are performing the different stages of the OSST under the influence of
systemic delivered opioid agonists.
Finally, it is well documented that chronic opioid administration (i.e. morphine)
leads to a wide range of neuroadaptations at different levels, including receptors,
intracellular signaling pathways, and synaptic morphology and plasticity (Christie, 2008).
Previous studies revealed that chronic morphine shifts PFC network activity state
progressively to an apparent normal functional state, despite the continuous presence of
morphine. Specifically, the acute systemic administration of morphine produces
increased PFC synchronization; however, repeated administration of morphine by day 3
leads to a complete reversal of these “abnormal” oscillatory network activities and
produces an apparent normalization of the activity in PFC (Dejean et al, 2013).
Moreover, treatment with the opioid antagonist naloxone promotes PFC synchronization
and withdrawal signs in morphine dependent rats (Dejean et al, 2013). These data

	
  

121	
  

suggests that chronic exposure to opioids promotes a new equilibrium in PFC that
requires the presence of morphine to endure, and to perform normal cognitive processing.
All the studies in this dissertation show results from an acute exposure to intra-LC
DAMGO. Given the different experimental conditions, it would be important to test how
these opioid-induced neuroadaptations after chronic exposure impact cognitive function
in both sexes. Furthermore, how changes in MOR expression levels, MOR receptor
density, and intracellular pathways activated by MOR promoted by chronic exposure to
opioids affects the LC-NE system, and whether there are sex differences at any of these
levels should be determined. Many of these questions lie beyond the scope of this
dissertation but inspire much future research.
Conclusion
These studies have provided concrete evidence for sex differences in opioid
regulation of the LC-NE system, revealed that female LC neurons are less sensitive to
opioid inhibition relative to male LC neurons, and evaluated sex differences in
physiological and behavioral correlates of LC-MOR activation. The findings from this
investigation have advanced our understanding of stress-related psychiatric disorders, and
may lead to improved treatment of patients suffering from stress-related psychiatric
disorders.
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Figures and Legends

	
  

Figure 16. Sex differences in MOR regulation of the LC-NE system and its
pathological consequences.
A) The opposing regulation model of LC activity during acute stress. Stress engages both
CRF and enkephalin (ENK) inputs that converge on LC neurons. CRF increases tonic
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activity, and this is associated with increased arousal. Activation of MORs on LC
neurons inhibits LC tonic discharge, and facilitates recovery of LC neurons after the
stressor is terminated. An imbalance in this opposing regulation model favoring CRF
may increase vulnerability to stress-related disorders characterized by hyperarousal.
Figure adapted from Valentino et al (2015). B) Schematic diagram showing the potential
physiological and cognitive consequences of sex differences in LC-MOR regulation in
the LC and the pathological implications. Abbreviations: PTSD, post-traumatic stress
disorder.
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